N-terminal acetyltransferases and Translation by Lyon,  Gholson J.
	   	  
N-­‐terminal	  acetyltransferases	  and	  
Transla2on	  
	  
Gholson	  J.	  Lyon,	  M.D.	  Ph.D.	  
“There	  are	  ~12	  billion	  nucleo<des	  in	  every	  cell	  of	  the	  human	  body,	  and	  there	  are	  
~25-­‐100	  trillion	  cells	  in	  each	  human	  body.	  Given	  soma<c	  mosaicism,	  epigene<c	  
changes	  and	  environmental	  diﬀerences,	  no	  two	  human	  beings	  are	  the	  same,	  
par<cularly	  as	  there	  are	  only	  ~7	  billion	  people	  on	  the	  planet”.	  	  






Nuclear	  pores	  in	  a	  yeast	  nucleus	  

Trimas<x	  pyriformis	  is	  a	  quadriﬂagellate,	  free-­‐living,	  bacterivorous	  
heterotrophic	  nanoﬂagellate	  from	  anoxic	  freshwaters	  that	  lacks	  mitochondria	  




Mara	  G.	  Hasel<ne	  is	  an	  interna<onally	  renowned	  ar<st	  known	  for	  her	  sculptural	  rendi<ons	  
of	  microscopic	  life	  forms	  -­‐	  including	  	  the	  large	  scale	  sculpture	  Waltz	  of	  the	  Polypep2des	  
that	  resides	  on	  CSHL	  grounds	  near	  Dolan	  depic<ng	  a	  ribosome	  crea<ng	  a	  protein.	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The translational apparatus is one of the major targets for antibiotics in the bacterial cell. Antibiotics predominantly interact with the functional centers of the ribosome, namely 
the messenger RNA (mRNA)-transfer RNA (tRNA) decoding region on the 30S subunit, the peptidyltransferase center on the 50S subunit, or the ribosomal exit tunnel through 
which the nascent polypeptide chain passes during translation. Protein synthesis can be divided into three phases: initiation, elongation, and termination/recycling.
1. Initiation
Translation initiation operates through a 30S initiation complex (30S-IC), consisting of the 30S, mRNA, initiator fMet-tRNA, and three initiation factors, IF1, IF2, and IF3. Sub-
sequently, the 30S-IC associates with the 50S, which releases the initiation factors (IFs) and leaves the initiator-tRNA at the peptidyl-tRNA-binding site (P site), base-paired to 
the start codon of the mRNA. The antibiotics edeine, GE81112, and kasugamycin interfere with 30S-IC assembly, whereas formation of a functional 70S-IC is blocked by the 
orthosomycins and pactamycins.
2. Elongation
The elongation phase involves the movement of tRNAs in a cyclic fashion through the three tRNA-binding sites (A→P→E) on the ribosome. The first step in the cycle involves 
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its dissociation from the ribosome, allowing aa-tRNA accommodation. Peptide-bond formation then proceeds, transferring the entire polypeptide chain from the P-tRNA to the 
aa-tRNA in the A site. The ribosome now has a peptidyl-tRNA at the A site and an uncharged tRNA at the P site. This ribosomal state is highly dynamic with the tRNAs oscil-
lating between classical (A and P sites) and hybrid states (A/P and P/E sites on 30S/50S). EF-G binds to the ribosome, which stabilizes the tRNAs in hybrid states, hydrolyzes 
GTP to GDP, and catalyzes the translocation reaction. Translocation shifts the peptidyl-tRNA from the A/P hybrid state to the P site and the deacylated tRNA from the P/E to the 
FYJUTJUF	&TJUF
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the elongation phase. Most antibiotics binding to the 30S perturb either tRNA binding, decoding, or translocation, whereas antibiotics targeting the 50S inhibit peptide-bond 
formation, extension of the polypeptide chain, or stable binding of translation factors. In contrast, some antibiotics interact directly with elongation factors and prevent them 
from dissociating from the ribosome.
3. Termination/Recycling
Arrival of an mRNA stop codon in the A site of the ribosome signals the termination of protein synthesis. Release factor 1 (RF1) or RF2 binds to the ribosome and hydrolyzes 
the peptidyl-tRNA bond, releasing the translated polypeptide chain from the ribosome. RF1/2 is recycled from the ribosome by RF3 in a GTP-dependent fashion. The ribosome 
is then split into subunits by the concerted action of EF-G and ribosome recycling factor (RRF), thus recycling the components for the next round of translation. There are no 
antibiotics that specifically inhibit termination and ribosome recycling; however antibiotics that target EF-G, such as α-sarcin, fusidic acid, and thiopeptides, also inhibit ribo-
some recycling.
Abbreviations
30S, small ribosomal subunit; 50S, large ribosomal subunit; aa-tRNA, aminoacyl-tRNA; A site, aa-tRNA-binding site; E site, exit site for tRNA; EF, elongation factor; IF, initiation 
factor; mRNA, messenger RNA; P-tRNA, peptidyl-tRNA; P site, P-tRNA-binding site; PTC, peptidyltransferase center; RRF, ribosome recycling factor; RF, release factor; tRNA, 
transfer RNA.
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Aminoglycosides Apramycin, gentamycin, hygromycin B, 
kanamycin, neomycin, paromomycin, 
tobramycin
Elongation (translocation) Most aminoglycoside antibiotics induce translational misreading by promoting 
binding of near-cognate tRNAs, but the biological effect is probably due to inhibition 
of the translocation reaction and promotion of back-translocation.
Edeine Edeine A Initiation (fMet-tRNA 
binding) 
Edeine prevents binding of the initiator tRNA to the 30S subunit in an mRNA-
dependent manner.
GE81112 GE81112 Initiation (fMet-tRNA 
binding) 
GE81112 inhibits binding of the initiator tRNA to the 30S subunit in an mRNA-
independent manner.
Kasugamycin Kasugamycin Initiation (fMet-tRNA 
binding) 
Kasugamycin inhibits translation initiation of canonical mRNAs by binding in the 
path of the mRNA and preventing stable interaction of the initiator tRNA with the 
start codon. 
Pactamycin Pactamycin Initiation, elongation 
(translocation) 
Early data suggest that pactamycin allows 30S but not 70S initiation complex 
formation, whereas recently pactamycin was shown to inhibit translocation in a 
tRNA-mRNA-dependent manner.
Spectinomycin Spectinomycin Elongation (translocation) Spectinomycin binds to the neck of the small subunit and prevents the relative 
movement of the head and body that is needed for the completion of translocation. 
Streptomycin Streptomycin Elongation (misreading) Streptomycin increases affinity of tRNA for the A site, has a modest inhibitory effect 
on translocation, promotes back-translocation, and induces high-level translational 
misreading.
Tetracyclines/glycylcyclines Doxycycline, minocycline, tetracycline/
tigecycline
Elongation (tRNA delivery) Tetracyclines prevent stable binding of the EF-Tu-tRNA-GTP ternary complex to 
the ribosome and inhibit accommodation of A-tRNAs upon EF-Tu-dependent GTP 
hydrolysis.
Viomycin Capreomycin, viomycin Elongation (translocation) Viomycin locks tRNAs in a hybrid-site translocation intermediate state, preventing 
conversion by EF-G into a posttranslocation state.
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Blasticidins Blasticidin S Elongation 
(peptidyltransferase) 
Two molecules of Blasticidin S mimic the C74 and C75 of P-tRNA and in doing 
so inhibit peptide bond formation by preventing tRNA binding at the P site of the 
peptidyltransferase center (PTC).
Chloramphenicols Chloramphenicol Elongation 
(peptidyltransferase) 
Chloramphenicol binds at the A site of the PTC where it perturbs placement of A 
site tRNA and thus prevents peptide bond formation.
Hygromycin A Hygromycin A Elongation 
(peptidyltransferase) 
Hygromycin A overlaps in its binding site with chloramphenicol and inhibits peptide 
bond formation by inhibiting the placement of the A site tRNA at the PTC.
Ketolides Cethromycin (ABT-773), telithromycin Elongation (nascent chain 
egress)  
Ketolides are derivatives of macrolides where the ketone group replaces the C3 
sugar. Ketolides exhibit the same mechanism of action as macrolides by blocking 
the ribosomal tunnel and inducing peptidyl-tRNA drop-off.
Lincosamides Clindamycin, lincomycin Elongation 
(peptidyltransferase) 
Lincosamides span across both A and P sites of the PTC and inhibit binding of 
tRNA substrates at both these sites.
Macrolides Azithromycin, carbomycin A, 
clarithromycin, erythromycin, 
spiramycin, troleandomycin, tylosin
Elongation (nascent chain 
egress) 
Macrolides bind within the ribosomal tunnel and prevent elongation of the nascent 
polypeptide chain, which leads to peptidyl-tRNA drop-off. Some macrolides, such 
as carbomycin A and tylosin, also directly inhibit peptide bond formation.
Orthosomycins Avilamycin, evernimicin Initiation (70S-IC formation) Orthosomycins interact with the large subunit and prevent the joining of the 30S-IC 
with the large subunit to form the 70S-IC in an IF2-dependent manner.
Oxazolidinones Eperezolid, linezolid Elongation 
(peptidyltransferase) 
Linezolid binds at the PTC in a position overlapping the aminoacyl moiety of 
A-tRNA, preventing tRNA accommodation and peptide bond formation.
Puromycin Puromycin Elongation 
(peptidyltransferase) 
Puromycin is a structural analog of the 3′ end of a tRNA, which binds at the A site of 
the PTC and triggers premature release of the nascent polypeptide chain.
Ribotoxins α-sarcin Elongation (translocation), 
recycling 
α-sarcin cleaves the E. coli 23S rRNA on the 3′ side of G2661, abolishing the 
ribosome’s ability to stimulate the GTP hydrolysis activity of translation factors, 
such as EF-G.
Sparsomycin Sparsomycin Elongation 
(peptidyltransferase) 
Sparsomycin binds at the PTC where it blocks tRNA binding at the A site, while 
promoting translocation and stabilization of tRNA at the P site.
Streptogramins A/B Dalfopristin/quinupristin, virginiamycin 
M/S
Elongation 
(peptidyltransferase) 
Streptogramins A and B act synergistically to inhibit translation. SA compounds 
bind at the PTC overlapping A and P sites, whereas SB compounds bind within the 
tunnel in a similar location to macrolides.
Thiopeptides Micrococcin, nocathiacin, nosiheptide, 
thiazomycin, thiostrepton
Elongation (translocation), 
Recycling 
Thiopeptide antibiotics inhibit translocation by blocking the stable binding of EF-G 
to the ribosome. Thiopeptides also inhibit the action of translational GTPases, such 
IF2 and EF-Tu.
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Fusidic acid Fusidic acid Elongation (translocation) Fusidic acid stabilizes EF-G on the ribosome by allowing binding and GTP 
hydrolysis, but not Pi release, nor the associated conformational changes in EF-G 
necessary for dissociation.
GE2270A-like thiopeptides Amythiamicins, GE2270A, thiomuracins Elongation (tRNA delivery) The GE2270A-like thiopeptides, like pulvomycin, prevent ternary complex formation 
by binding to EF-Tu and blocking interaction of EF-Tu with aminoacyl-tRNAs. 
GE2270A and pulvomycin have distinct but overlapping binding sites on EF-Tu.
Kirromycins and enacyloxins Aurodox, kirromycin, and enacyloxin IIa Elongation (tRNA delivery) These drugs trap EF-Tu on the ribosome by allowing GTP hydrolysis but preventing 
Pi release and the conformational changes in EF-Tu that are necessary for tRNA 
release and EF-Tu dissociation.
Pulvomycin Pulvomycin Elongation (tRNA delivery) Pulvomycin prevents ternary complex formation by binding to EF-Tu and blocking 
interaction of EF-Tu with aminoacyl-tRNAs.
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Introduction
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perform the same functions in different organisms should
be assigned the same name. Homologous macromol-
ecules are the products of genes that have evolved from
a common ancestor. The fact that two macromolecules
are homologous can often be established simply by com-
paring their sequences, but sometimes it becomes appar-
ent only after their three-dimensional structures have
been determined so that comparisons can be done using
structure-based sequence alignments.
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function as bL12, but which are not homologous to it, are
called P1 and P2. In yeast, multiple forms of this protein
are found: P1A, P1B, P2A, and P2B. Sometimes there is
also a variant called P3, which is found exclusively in
plants. We suggest that these names be retained. Further-
more, we suggest that capital letters following protein
names be used to distinguish different isoforms of the
same protein, when appropriate. The functional equiv-
alent of bL12 in archaea has been called L12, but this is
inappropriate since in sequence, that protein is closely
related to P1, but not at all to bL12. Since there is only
one variant we suggest that it can be called P1.
We note that the use of lower case prefixes before LY and
SX names is a departure from prior practice that should
168 Nucleic acids and their protein complexes
Table 1
New nomenclature for proteins from the small ribosomal
subunit.
New
name#
Taxonomic
range*
Bacteria
name
Yeast
name
Human
name
bS1 B S1 – –
eS1 A E – S1 S3A
uS2 B A E S2 S0 SA
uS3 B A E S3 S3 S3
uS4 B A E S4 S9 S9
eS4 A E – S4 S4
uS5 B A E S5 S2 S2
bS6 B S6 – –
eS6 A E – S6 S6
uS7 B A E S7 S5 S5
eS7 E – S7 S7
uS8 B A E S8 S22 S15A
eS8 A E – S8 S8
uS9 B A E S9 S16 S16
uS10 B A E S10 S20 S20
eS10 E – S10 S10
uS11 B A E S11 S14 S14
uS12 B A E S12 S23 S23
eS12 E – S12 S12
uS13 B A E S13 S18 S18
uS14 B A E S14 S29 S29
uS15 B A E S15 S13 S13
bS16 B S16 – –
uS17 B A E S17 S11 S11
eS17 A E – S17 S17
bS18 B S18 – –
uS19 B A E S19 S15 S15
eS19 A E – S19 S19
bS20 B S20 – –
bS21 B S21 – –
bTHX B THX – –
eS21 E – S21 S21
eS24 A E – S24 S24
eS25 A E – S25 S25
eS26 E – S26 S26
eS27 A E – S27 S27
eS28 A E – S28 S28
eS30 A E – S30 S30
eS31 A E – S31 S27A
RACK1 E – Asc1 RACK1
# b: bacterial, e: eukaryotic, u: universal.
* B: bacteria, A: archaea, E: eukaryotes.
Table 2
Nomenclature for proteins from the large ribosomal subunit.
New
name#
Taxonomic
range*
Bacteria
name
Yeast
name
Human
name
uL1 B A E L1 L1 L10A
uL2 B A E L2 L2 L8
uL3 B A E L3 L3 L3
uL4 B A E L4 L4 L4
uL5 B A E L5 L11 L11
uL6 B A E L6 L9 L9
eL6 E – L6 L6
eL8 A E – L8 L7A
bL9 B L9 – –
uL10 B A E L10 P0 P0
uL11 B A E L11 L12 L12
bL12 B L7/L12 – –
uL13 B A E L13 L16 L13A
eL13 A E – L13 L13
uL14 B A E L14 L23 L23
eL14 A E – L14 L14
uL15 B A E L15 L28 L27A
eL15 A E – L15 L15
uL16 B A E L16 L10 L10
bL17 B L17 – –
uL18 B A E L18 L5 L5
eL18 A E – L18 L18
bL19 B L19 – –
eL19 A E – L19 L19
bL20 B L20 – –
eL20 E – L20 L18A
bL21 B L21 – –
eL21 A E – L21 L21
uL22 B A E L22 L17 L17
eL22 E – L22 L22
uL23 B A E L23 L25 L23A
uL24 B A E L24 L26 L26
eL24 A E – L24 L24
bL25 B L25 – –
bL27 B L27 – –
eL27 E – L27 L27
bL28 B L28 – –
eL28 E – – L28
uL29 B A E L29 L35 L35
eL29 E – L29 L29
uL30 B A E L30 L7 L7
eL30 A E – L30 L30
bL31 B L31 – –
eL31 A E – L31 L31
bL32 B L32 – –
eL32 A E – L32 L32
bL33 B L33 – –
eL33 A E – L33 L35A
bL34 B L34 – –
eL34 A E – L34 L34
bL35 B L35 – –
bL36 B L36 – –
eL36 E – L36 L36
eL37 A E – L37 L37
eL38 A E – L38 L38
eL39 A E – L39 L39
eL40 A E – L40 L40
eL41 A E – L41 L41
eL42 A E – L42 L36A
eL43 A E – L43 L37A
P1/P2 A E – P1/P2 (AB) P1/P2 (ab)
# b: bacterial, e: eukaryotic, u: universal.
* B: bacteria, A: archaea, E: eukaryotes.
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function as bL12, but which are not homologous to it, are
called P1 and P2. In yeast, multiple forms of this protein
are found: P1A, P1B, P2A, and P2B. Sometimes there is
also a variant called P3, which is found exclusively in
plants. We suggest that these names be retained. Further-
more, we suggest that capital letters following protein
names be used to distinguish different isoforms of the
same protein, when appropriate. The functional equiv-
alent of bL12 in archaea has been called L12, but this is
inappropriate since in sequence, that protein is closely
related to P1, but not at all to bL12. Since there is only
one variant we suggest that it can be called P1.
We note that the use of lower case prefixes before LY and
SX names is a departure from prior practice that should
168 Nucleic acids and their protein complexes
Table 1
New nomenclature for proteins from the small ribosomal
subunit.
New
name#
Taxonomic
range*
Bacteria
name
Yeast
name
Human
name
bS1 B S1 – –
eS1 A E – S1 S3A
uS2 B A E S2 S0 SA
uS3 B A E S3 S3 S3
uS4 B A E S4 S9 S9
eS4 A E – S4 S4
uS5 B A E S5 S2 S2
bS6 B S6 – –
eS6 A E – S6 S6
uS7 B A E S7 S5 S5
eS7 E – S7 S7
uS8 B A E S8 S22 S15A
eS8 A E – S8 S8
uS9 B A E S9 S16 S16
uS10 B A E S10 S20 S20
eS10 E – S10 S10
uS11 B A E S11 S14 S14
uS12 B A E S12 S23 S23
eS12 E – S12 S12
uS13 B A E S13 S18 S18
uS14 B A E S14 S29 S29
uS15 B A E S15 S13 S13
bS16 B S16 – –
uS17 B A E S17 S11 S11
eS17 A E – S17 S17
bS18 B S18 – –
uS19 B A E S19 S15 S15
eS19 A E – S19 S19
bS20 B S20 – –
bS21 B S21 – –
bTHX B THX – –
eS21 E – S21 S21
eS24 A E – S24 S24
eS25 A E – S25 S25
eS26 E – S26 S26
eS27 A E – S27 S27
eS28 A E – S28 S28
eS30 A E – S30 S30
eS31 A E – S31 S27A
RACK1 E – Asc1 RACK1
# b: bacterial, e: eukaryotic, u: universal.
* B: bacteria, A: archaea, E: eukaryotes.
Table 2
Nomenclature for proteins from the large ribosomal subunit.
New
name#
Taxonomic
range*
Bacteria
name
Yeast
name
Human
name
uL1 B A E L1 L1 L10A
uL2 B A E L2 L2 L8
uL3 B A E L3 L3 L3
uL4 B A E L4 L4 L4
uL5 B A E L5 L11 L11
uL6 B A E L6 L9 L9
eL6 E – L6 L6
eL8 A E – L8 L7A
bL9 B L9 – –
uL10 B A E L10 P0 P0
uL11 B A E L11 L12 L12
bL12 B L7/L12 – –
uL13 B A E L13 L16 L13A
eL13 A E – L13 L13
uL14 B A E L14 L23 L23
eL14 A E – L14 L14
uL15 B A E L15 L28 L27A
eL15 A E – L15 L15
uL16 B A E L16 L10 L10
bL17 B L17 – –
uL18 B A E L18 L5 L5
eL18 A E – L18 L18
bL19 B L19 – –
eL19 A E – L19 L19
bL20 B L20 – –
eL20 E – L20 L18A
bL21 B L21 – –
eL21 A E – L21 L21
uL22 B A E L22 L17 L17
eL22 E – L22 L22
uL23 B A E L23 L25 L23A
uL24 B A E L24 L26 L26
eL24 A E – L24 L24
bL25 B L25 – –
bL27 B L27 – –
eL27 E – L27 L27
bL28 B L28 – –
eL28 E – – L28
uL29 B A E L29 L35 L35
eL29 E – L29 L29
uL30 B A E L30 L7 L7
eL30 A E – L30 L30
bL31 B L31 – –
eL31 A E – L31 L31
bL32 B L32 – –
eL32 A E – L32 L32
bL33 B L33 – –
eL33 A E – L33 L35A
bL34 B L34 – –
eL34 A E – L34 L34
bL35 B L35 – –
bL36 B L36 – –
eL36 E – L36 L36
eL37 A E – L37 L37
eL38 A E – L38 L38
eL39 A E – L39 L39
eL40 A E – L40 L40
eL41 A E – L41 L41
eL42 A E – L42 L36A
eL43 A E – L43 L37A
P1/P2 A E – P1/P2 (AB) P1/P2 (ab)
# b: bacterial, e: eukaryotic, u: universal.
* B: bacteria, A: archaea, E: eukaryotes.
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SUMMARY
Cotranslational protein translocation is a universally
conserved process for secretory andmembrane pro-
tein biosynthesis. Nascent polypeptides emerging
from a translating ribosome are either transported
across or inserted into the membrane via the ribo-
some-bound Sec61 channel. Here, we report struc-
tures of a mammalian ribosome-Sec61 complex in
both idle and translating states, determined to 3.4
and 3.9 A˚ resolution. The data sets permit building
of a near-complete atomic model of the mammalian
ribosome, visualization of A/P and P/E hybrid-state
tRNAs, and analysis of a nascent polypeptide in
the exit tunnel. Unprecedented chemical detail is
observed for both the ribosome-Sec61 interaction
and the conformational state of Sec61 upon ribo-
some binding. Comparison of the maps from idle
and translating complexes suggests how conforma-
tional changes to the Sec61 channel could facilitate
translocation of a secreted polypeptide. The high-
resolution structure of the mammalian ribosome-
Sec61 complex provides a valuable reference for
future functional and structural studies.
INTRODUCTION
The maturation of nascent polypeptides relies on many factors
that dynamically associate with the translating ribosome. These
factors include modification enzymes, chaperones, targeting
complexes, and protein translocons. While many fundamental
aspects of protein translation are now understood in chemical
detail (Voorhees and Ramakrishnan, 2013), far less is known
about how these exogenous factors cooperate with the ribo-
some to facilitate nascent chain maturation.
Amajor classofproteins that relyextensivelyon ribosome-asso-
ciated machinery are secreted and integral membrane proteins
(Nyathi et al., 2013). In all organisms, a large proportion of these
proteins are cotranslationally translocated across or inserted into
the membrane. The exceptional prominence of this pathway in
mammals is underscored by the original discovery of ribosomes
as a characteristic feature of the endoplasmic reticulum mem-
brane (Palade, 1955). Thus, understanding the nature of mem-
brane-bound ribosomes and their role in secretory protein biosyn-
thesis has been a long-standing goal in cell biology.
After targeting to the membrane (Egea et al., 2005), ribosomes
synthesizing nascent secretory and membrane proteins dock
at a universally conserved protein conducting channel (PCC),
called the Sec61 complex in eukaryotes and the SecY complex
in prokaryotes and archaea (Park and Rapoport, 2012). The PCC
has two basic activities. First, it provides a conduit across
the membrane through which hydrophilic polypeptides can be
translocated. Second, it recognizes hydrophobic signal peptides
and transmembrane domains and releases them laterally into the
lipid bilayer.
These activities rely on binding partners that regulate PCC
conformation and provide the driving force for vectorial translo-
cation of the nascent polypeptide. The best characterized trans-
location partners are the ribosome and the prokaryote-specific
ATPase SecA. Extensive functional and structural studies of
the SecA-SecY posttranslational translocation system, in paral-
lel with the cotranslational ribosome-Sec61 system, have coa-
lesced into a general framework for protein translocation (Park
and Rapoport, 2012).
Over the past two decades several crystal structures and
cryo-EM reconstructions have led to numerous mechanistic
insights into these events. High-resolution crystal structures of
the large ribosomal subunit visualized the exit tunnel (Nissen
et al., 2000), whose conserved conduit was shown to align
with a bound Sec61 complex (Beckmann et al., 1997). While
structural analysis of the prokaryotic ribosome and translation
cycle progressed rapidly (Schmeing and Ramakrishnan, 2009),
the lower resolution of parallel PCC structures (Menetret et al.,
2000; Beckmann et al., 2001) posed a challenge to identifying
changes in its conformation at different stages of translocation.
A major advance was the crystal structure of the archaeal
SecYEb complex (Van den Berg et al., 2004), whichmade several
predictions about the nature and function of the translocation
channel that were supported by later studies. The ten transmem-
brane segments of SecY are arranged in a pseudosymmetric
orientationsuch that the twohalves (formedbyhelices1-5andhe-
lices 6-10) surround an hourglass-shaped pore occluded by the
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techniques (Scheres, 2010; Scheres, 2012b). Our initial data set
contained 80,019 ribosomal particles. In silico classification
of these particles (Figure S2) ag ees with several spects of its
biochemical characterization. First, nearly all ribosomes con-
tained a bound translocon, as classification of the final sample
could not isolate any translocon-free ribosomes. Second, while
the density for the area surrounding the translocon was hetero-
geneous due to a combination of accessory factors and the
detergent-lipid micelle, very high occupancy was observed for
the central Sec61 complex. Third, multiple classes of particles
could be sorted based on the conformation of the ribosome
and included translating and idle populations. The complete
data set and individual classes were separately analyzed to
extract their best features, which were incorporated into a com-
posite model for the complete 80S-Sec61 complex.
An initial reconstruction using the entire data set was calcu-
lated using a mask for the 60S subunit to avoid interference in
the angular assignment by the heterogeneous conformation of
the 40S. The resulting map, determined to 3.35 A˚ resolution,
was used to build the ribosomal RNA and proteins of the 60S
subunit. A distinctive class of !13% of particles contained two
tRNAs bound in the A/P and P/E hybrid state. These particles
were used to generate a 3.9 A˚ resolution map of the translating
ribosome-translocon complex, within which density for the
nascent polypeptide was observed throughout the ribosomal
tunnel. The remaining 69,464 particles lacking tRNA and a
nascent peptide were considered nontranslating ribosomes.
This class was processed using a 60Smask to build the idle ribo-
some-Sec61 map at 3.4 A˚ resolution. Finally, this idle class was
further subdivided by the degree of ribosomal ratcheting, and the
presence or absence of the translational GTPase eEF2. One of
these subclasses contained 36,667 particles and was used
to produce a 3.5 A˚ resolution map used for building of the 40S
ribosomal subunit and a well-ordered lateral stalk region. Thus,
by lever ging major advances in both image detection and
in silico analysis, a relatively small and heterogeneous data set
could be used to build a near-complete atomic model of the
mammalian 80S ribosome and high-resolution structures for
the Sec61 complex bound to the translating and idle ribosome
(see overview in Figure 1A). We will begin by presenting
the structure of the 80S ribosome, followed by discussion of
the Sec61 complex structure and its functional implications.
Throughout this study, we use the new unified nomenclature
for ribosomal proteins (see Table S1; Ban et al., 2014).
An Atomic Model of the Mammalian Ribosome
The porcine ribosome described in this study was determined
to an average resolution of 3.4 and 3.5 A˚ for the 60 and 40S,
respectively (Figure S3, Table S2), as judged by the ‘‘gold-stan-
dard’’ Fourier Shell Correlation (FSC = 0.143) criterion (Scheres
and Chen, 2012). Notably, much of the core of the 60S subunit
is at 3.0 A˚ resolution or better (Figure 1B), while the head of the
40S subunit, given its inherent flexibility, is at somewhat lower
resolution. The distal regions of several metazoan-specific
rRNA expansion segments, such as ES27L, protrude from the
ribosome and are presumably dynamic (Anger et al., 2013). As
in the earlier study, these regions of rRNA were not visualized
in our averaged maps. As the sample was prepared from an
actively translating tissue, there was no evidence for binding
of Stm1 or other sequestration factors that were observed in pre-
vious studies (Anger et al., 2013; Ben-Shem et al., 2011).
Using a recent model of the human ribosome generated at
!5.4 A˚ resolution as a starting point (Anger et al., 2013), we
have rebuilt each ribosomal protein and the rRNA, including
many amino acid side chains, RNA bases, and over 100 Mg2+
ions (Figure 2). Our density map allowed de novo building
of many regions that were previously approximated due to
lower resolution (Figure S4A). Additional eukaryote-specific
Figure 1. The Structure of a Mammalian Ribosome-Translocon Complex
(A) Model of the idle 80S ribosome in complex with Sec61, shown in red. The color scheme shown here is used throughout the manuscript: 40S rRNA is displayed
in orange, the 40S ribosomal proteins in brown, the 60S rRNA in cyan, and the 60S ribosomal proteins in dark blue. The region of the peptidyl transferase center
(PTC) is indicated.
(B) Cut view of the final unshar ned cryo-EM density map for both the i le 60S-Sec61 complex a d the 40S subunit, colored by local resolution in A˚ (Kucukelbir
et al., 2014). Also see Figure S3.
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Sec61a. The central pore was sufficiently large to house a model
of an extended polypeptide without clashes.
While the plug’s canonical position was not occupied in the
active state, we could not unambiguously assign it to an alternate
location. It is possible the plu adopts a variety of conform tions
in this sample (given the heterogen ous seq ences of transl -
cating nascent chains) or becomes disordered to allow translo-
cation. Given that the plug can be crosslinked to several dispa-
rate resid es within an active SecY, it is likely dynamic once
freed from its interactions with the pore ring. This flexibility may
be facilitated by the observed movements in helix 1. In the static
situation of a stalled nascent chain (G gala t al., 2014), the plug
may settle at its lowest energy state, perhaps explaining why it
was apparently seen near its original location. However steric
constraints would require at least a nominal shift in the plug to
accommodate the nascent peptide within the central pore.
Alth ugh f w r particles for the active S c61 complex led to a
lower-resolution map than that for the idle complex, some areas
are better resolved than others (Figures S6A and S6B). Helices 6-
9, along with loops 6/7 and 8/9, display the highest resolution
within the structure as judged by atomic B-factor (Figure S6C).
This provides confidence in c ncluding that this part of Sec61
has few if any substantive conformational changes relative to
the idle state. Thus, the C-terminal half of Sec61 effectively forms
a stable platform for ribosome interaction.
By contrast, the density for helices 2-4 is significantly weaker
than for either this same region in the idle Sec61 structure, or f r
helices 6-9 in the active structure (Figure S6). This observation
strongly argues that the position of helices 2-4 in the active
Sec61 is heterogeneous. Several nonmutually exclusive expla-
nations are possible: (i) heterogeneous clients at different stages
of transloction; (ii) different accessory proteins acting during
translocati n; nd (iii) inherent flexibility this region w n the
plug is displaced. Irrespective of the specific explanation (s), it
would seem clear that helices 6-9 provide a ribosome-stabilized
fulcrum, which allowsmovements within the remaining portion of
the molecule to accommodate the nascent chain.
Implications for Cotranslational Protein Translocation
The structures described here help refine our understanding
of several steps during cotranslational protein translocation
and provide mechanistic insights into the two stages for fully
activating the Sec61 channel (Figure 7). In the quiescent state
presumably represented by the isolated crystal structure (Van
den Berg et al., 2004), the channel is fully closed to both the
lumen and lipid bilayer. The first stage of activation involves
binding of the ribosome, which primes the channel by opening
of the cytosolic side of the lateral gate, thereby decreasing the
energetic barrier for translocation. The movement of helix 2,
implicated as part of this priming reaction, may provide a hydro-
phobic docking site for the arriving signal peptide in this region.
Importantly, this primed state leaves the channel largely closed
to membrane and entirely closed to the ER lumen.
In the second stage of activation, a suitable substrate can now
exploit the primed Sec61 by binding to and further opening the
lateral gate. Signal peptide engagement at the lateral gate results
in destabilization of the plug from the pore ring, either by steri-
cally pushing the plug out of position, or by opening of the lateral
gate, which shifts the helices surrounding the plug. Such a state
appears to have been captured at low resolution in the E. coli
system (Park et al., 2014). This model would rationalize why pro-
miscuously targeted nonclients are rejected by Sec61, prior to
gaining ac ess t the lumenal environment (Jungnickel and
Rapoport, 1995). The model would also explain how a small
molecule that seems to bind near the plug can allosterically
inhibit a signal sequence from successfully engaging Sec61
(Mackinnon et al., 2014).
Once the plug is destabilized, the translocating nascent chain
can enter the channel, which sterically prevents the plug from
adopting its steady-state conformation.Adynamicplugno longer
stabilizes the surrounding helices at the central pore, permitting
a more dynamic lateral gate. This flexibility may permit sampling
of the lipid bilayer by the translocating nascent chain, thereby al-
lowing suitably hydr phobic elements to insert in the membrane.
This model for activation provides one explanation for why trans-
membrane segments within a multispanning membrane protein
can be far less hydrophobic than those that engage the Sec61
channel de novo: the latter would need to fully open a nearly-
closed lateral g te stabilized by the plug, while the former could
take advantage of a gate made dynamic by plug displacement.
Both before and during translocation, a constant feature of
the native ribosome-translocon complex is the substantial gap
cytosol
lumen
TranslocatingQuiescent
H2/3
L6/7
Plug
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Plug
Primed
H2/3
L6/7
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Figure 7. A Two-Step Model for Activation
of Sec61
Displayed here is a cut-away view of the model for
the Sec channel from the central pore toward the
lateral gate (dashed line). In the quiescent state
(left), approximated by a crystal structure of the
archaeal SecY complex (Van den Berg et al.,
2004), the Sec channel is closed to both the lumen
and lipid bilayer. The channel becomes primed
for protein translocation upon ribosome binding
(middle), triggering conformational changes in
Sec61 that crack the cytosolic side of the lateral
gate (demarcated by an asterisk). The movements
of helices 2 and 3 in this region may create an
in tial binding site for signal peptide recognition.
Engagement of the lateral gate by the signal peptide would open the channel toward themembrane and initiate translocation (not depicted; Park et al., 2014). The
translocating state of the active ribosome-Sec61 complex (right) contains a nascent polypeptide (teal) and is characterized by a dynamic plug domain and an
open conduit between the cytosol and lumen (teal dotted line).
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Map 1: 80S-Sec61
80,019 particles (3.4 Å)
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Map 5: 80S-Sec61-eEF2
36,667 particles (3.5 Å)
Map 3: Active 80S-Sec61
10,555 + 4,168 particles* (3.9 Å)
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particles from two datasets
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Figure S2. Refinement and 3D Classification Strategy, Related to Experimental Procedures
Each class in the displayed flowchart shows a cross section image of the respectivemap, the derivedmodel, anymask that was applied (red dashed line), and the
structure (s) derived from that class (red text). The complete data set containing 80,019 particles was refined using RELION (Scheres, 2012a, 2012b), resulting in
an initial reconstruction calculated to 3.4 A˚ resolution (Map 1). As the 40S subunit was in a variety of distinct conformations, a soft mask for the 60S subunit was
used throughout the refinement procedure (Map 2). Although this only resulted in a modest nominal increase in resolution (3.35 A˚), the observed density for the
60S subunit was improved compared to the complete refinement, and was used to build the 60S ribosomal proteins and RNA. In parallel, 3D classification of the
entire data set identified 13% of particles containing hybrid A/P- and P/E-site tRNAs and a nascent peptide. In order to supplement this relatively small class, an
additional data set was collected, resulting in a combined14,723 particles used to build the translating ribosome-Sec61 complex to 3.9 A˚ resolution (Map 3). The
remaining 87%of particles (69,464) were used to model the idle ribosome-Sec61 complex, lacking a nascent chain and tRNAs, to 3.4 A˚ resolution (Map 4). Within
this idle class, 36,667 particles containing eEF2, which stabilized both the stalk base proteins and the orientation of the 40S subunit relative to the 60S (Map 5).
This class of particles was used to build a model for the 40S ribosomal proteins and RNA at 3.5 A˚ resolution. The remaining idle particles either contained eEF2
bound in different ratcheted conformations (19%) or were devoid of tRNAs or factors (22%). All reported resolutions are determined using the gold-standard
Fourier Shell Correlation (FSC = 0.143) criterion (Scheres and Chen, 2012), and are shown in Figure S3.
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Figure S2. Refinement and 3D Classification Strategy, Related to Experimental Procedures
Each class in the displayed flowchart shows a cross section image of the respectivemap, the derivedmodel, anymask that was applied (red dashed line), and the
structure (s) derived from that class (red text). The complete data set containing 80,019 particles was refined using RELION (Scheres, 2012a, 2012b), resulting in
an initial reconstruction calculated to 3.4 A˚ resolution (Map 1). As the 40S subunit was in a variety of distinct conformations, a soft mask for the 60S subunit was
used throughout the refinement procedure (Map 2). Although this only resulted in a modest nominal increase in resolution (3.35 A˚), the observed density for the
60S subunit was improved compared to the complete refinement, and was used to build the 60S ribosomal proteins and RNA. In parallel, 3D classification of the
entire data set identified 13% of particles containing hybrid A/P- and P/E-site tRNAs and a nascent peptide. In order to supplement this relatively small class, an
additional data set was collected, resulting in a combined14,723 particles used to build the translating ribosome-Sec61 complex to 3.9 A˚ resolution (Map 3). The
remaining 87%of particles (69,464) were used to model the idle ribosome-Sec61 complex, lacking a nascent chain and tRNAs, to 3.4 A˚ resolution (Map 4). Within
this idle class, 36,667 particles containing eEF2, which stabilized both the stalk base proteins and the orientation of the 40S subunit relative to the 60S (Map 5).
This class of particles was used to build a model for the 40S ribosomal proteins and RNA at 3.5 A˚ resolution. The remaining idle particles either contained eEF2
bound in different ratcheted conformations (19%) or were devoid of tRNAs or factors (22%). All reported resolutions are determined using the gold-standard
Fourier Shell Correlation (FSC = 0.143) criterion (Scheres and Chen, 2012), and are shown in Figure S3.
Cell 157, 1632–1643, June 19, 2014 ª2014 The Authors S5
techniques (Scheres, 2010; Scheres, 2012b). Our initial data set
contained 80,019 ribosomal particles. In silico classification
of these particles (Figure S2) agrees with several aspects of its
biochemical characterization. First, nearly all ribosomes con-
tained a bound translocon, as classification of the final sample
could not isolate any translocon-free ribosomes. Second, while
the density for the area surrounding the translocon was hetero-
geneous due to a combination of accessory factors and the
detergent-lipid micelle, very high occupancy was observed for
the central Sec61 complex. Third, multiple classes of particles
could be sorted based on the conformation of the ribosome
and included translating and idle populations. The complete
data set and individual classes were separately analyzed to
extract their best features, which were incorporated into a com-
posite model for the complete 80S-Sec61 complex.
An initial reconstruction using the entire data set was calcu-
lated using a mask for the 60S subunit to avoid interference in
the angular assignment by the heterogeneous conformation of
the 40S. The resulting map, determined to 3.35 A˚ resolution,
was used to build the ribosomal RNA and proteins of the 60S
subunit. A distinctive class of !13% of particles contained two
tRNAs bound in the A/P and P/E hybrid state. These particles
were used to generate a 3.9 A˚ resolution map of the translating
ribosome-translocon complex, within which density for the
nascent polypeptide was observed throughout the ribosomal
tunnel. The remaining 69,464 particles lacking tRNA and a
nascent peptide were considered nontranslating ribosomes.
This class was processed using a 60Smask to build the idle ribo-
some-Sec61 map at 3.4 A˚ resolution. Finally, this idle class was
further subdivided by the degree of ribosomal ratcheting, and the
presence or absence of the translational GTPase eEF2. One of
these subclasses contained 36,667 particles and was used
to produce a 3.5 A˚ resolution map used for building of the 40S
ribosomal subunit and a well-ordered lateral stalk region. Thus,
by leveraging major advances in both image detection and
in silico analysis, a relatively small and heterogeneous data set
could be used to build a near-complete atomic model of the
mammalian 80S ribosome and high-resolution structures for
the Sec61 complex bound to the translating and idle ribosome
(see overview in Figure 1A). We will begin by presenting
the structure of the 80S ribosome, followed by discussion of
the Sec61 complex structure and its functional implications.
Throughout this study, we use the new unified nomenclature
for ribosomal proteins (see Table S1; Ban et al., 2014).
An Atomic Model of the Mammalian Ribosome
The porcine ribosome described in this study was determined
to an average resolution of 3.4 and 3.5 A˚ for the 60 and 40S,
respectively (Figure S3, Table S2), as judged by the ‘‘gold-stan-
dard’’ Fourier Shell Correlation (FSC = 0.143) criterion (Scheres
and Chen, 2012). Notably, much of the core of the 60S subunit
is at 3.0 A˚ resolution or better (Figure 1B), while the head of the
40S subunit, given its inherent flexibility, is at somewhat lower
resolution. The distal regions of several metazoan-specific
rRNA expansion segments, such as ES27L, protrude from the
ribosome and are presumably dynamic (Anger et al., 2013). As
in the earlier study, these regions of rRNA were not visualized
in our averaged maps. As the sample was prepared from an
actively translating tissue, there was no evidence for binding
of Stm1 or other sequestration factors that were observed in pre-
vious studies (Anger et al., 2013; Ben-Shem et al., 2011).
Using a recent model of the human ribosome generated at
!5.4 A˚ resolution as a starting point (Anger et al., 2013), we
have rebuilt each ribosomal protein and the rRNA, including
many amino acid side chains, RNA bases, and over 100 Mg2+
ions (Figure 2). Our density map allowed de novo building
of many regions that were previously approximated due to
lower resolution (Figure S4A). Additional eukaryote-specific
Figure 1. The Structure of a Mammalian Ribosome-Translocon Complex
(A) Model of the idle 80S ribosome in complex with Sec61, shown in red. The color scheme shown here is used throughout the manuscript: 40S rRNA is displayed
in orange, the 40S ribosomal proteins in brown, the 60S rRNA in cyan, and the 60S ribosomal proteins in dark blue. The region of the peptidyl transferase center
(PTC) is indicated.
(B) Cut view of the final unsharpened cryo-EM density map for both the idle 60S-Sec61 complex and the 40S subunit, colored by local resolution in A˚ (Kucukelbir
et al., 2014). Also see Figure S3.
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extensions of ribosomal proteins previouslymodeled by second-
ary structure predictions were also visible and built de novo
(Figure S4B). The ribosome stalk was stabilized in the class of
particles containing eEF2, which facilitated modeling at high
resolution in this region (Figure S4C and S4D). As a result, we
were able to build a near-complete 80S mammalian ribosome
at atomic resolution. The marked improvement in the model is
evident from the reduction of Ramachandran outliers within the
ribosomal proteins from !13% (Anger et al., 2013) to !5.4%
for the 60S subunit and !7.5% for the 40S (Table S2). The low
percentage of Ramachandran outliers suggests the quality
of our mammalian cryo-EM model is comparable to that of
the seminal S. cerevisiae ribosome crystal structure determined
to 3.0 A˚ resolution (Ben-Shem et al., 2011).
Unlike in bacteria, the eukaryotic ribosome relies on extensive
protein-protein interactions (Ben-Shem et al., 2011; Anger et al.,
2013), and the improved model presented here illustrates many
of the detailed chemical interactions that stabilize the mamma-
lian ribosome. For example, ribosomal proteins eL21 and uL30
together each contribute one strand of a b sheet, while stacking
interactions are observed between a phenylalanine in eL20 and
the 28S rRNA. Additionally, though eEF2 was bound in a non-
physiological state without P-site tRNA, its interactions with
ribosomal proteins uL10 and uL11 can be observed at high res-
olution (Figures S4C and S4D). Given the high degree of confi-
dence we now have in the model, and the extremely high
sequence conservation of the ribosome in all mammals (Table
S1), this structure will serve as a resource for future biochemical
and structural experiments.
Hybrid State tRNAs in an Actively Translating Ribosome
The translating ribosome-translocon structure contained hybrid
state A/P- and P/E-site tRNAs and a nascent polypeptide. The
conformation of the P/E tRNA is similar to earlier reports (Tour-
igny et al., 2013; Dunkle et al., 2011) and stabilizes the L1 stalk
inward. However, as previous reconstructions of an A/P tRNA
Figure 2. Representative Density for the Ri-
bosomal Proteins and rRNA
(A–D) Cryo-EM density for the 60S subunit and the
body of the 40S was sufficient to allow unambig-
uous placement of rRNA bases (A, C, D) amino
acid side chains (B, C, D), and many ions (D). Also
see Figure S4.
were limited to !9 A˚ resolution (Agirreza-
bala et al., 2008; Julia´n et al., 2008), our
structure represents the first high-resolu-
tion visualization of an A/P tRNA bound
to the ribosome (Figure 3A). Though the
sample contains a mixture of tRNA spe-
cies, it was nevertheless possible to
infer the global conformational changes
required to adopt this hybrid conforma-
tion (Figures 3B and 3C).
In order to simultaneously bind the
A-site mRNA codon and the 60S P site,
the body of the tRNA must bend by !13"
when compared to a canonical A-site tRNA (Voorhees et al.,
2009). Notably, the CCA tail of the A/P tRNA does not superim-
pose with the 30 end of a canonical P-site tRNA, presumably
because in the hybrid state the 60S subunit is in a different
orientation relative to the 40S. Thus, the hybrid A/P conformation
is accomplished by an !9 A˚ displacement of the CCA tail, com-
parable to that observed in reconstructions of the bacterial com-
plex (Agrawal et al., 2000), and by bending in two regions of the
tRNA: the anticodon stem loop, and the acceptor/T-stem stack.
Similar regions have been implicated in binding of tRNAs to the
ribosome in other noncanonical conformations (Schmeing et al.,
2009). In particular, mutations in the anticodon stem loop have
profound functional effects (Hirsh and Gold, 1971; Hirsh, 1971),
as these mutations perturb the flexibility of the tRNA body and
thus the energy required for adoption of these distorted confor-
mations (Schmeing et al., 2011, 2009). Similarly, the A/P tRNA is
undoubtedly a high-energy state stabilized by the presence of a
nascent chain, which is discussed in further detail below. The
instability of these intermediate tRNA conformations may favor
movement of tRNAs and mRNA through the ribosome, facili-
tating translocation. Thus visualization of an A/P hybrid state
further supports the notion that flexibility within the tRNA body
must be precisely tuned to the requirements of the ribosome dur-
ing protein synthesis.
Overview of the Ribosome-Sec61 Structures
In addition to the high-resolution model of the ribosome pre-
sented above, analysis of the 80S-Sec61 complex afforded
new insights into the role of Sec61 in translocation. The final
models of a porcine ribosome-Sec61 complex in both an idle
and translating state were determined to 3.4 and 3.9 A˚ resolution
(Figures 1B, S2, and S3). Local resolution analysis of a cut away
of the 60S subunit bound to Sec61 showed that the cytosolic re-
gions of the idle Sec61 complex are at a similar resolution to the
ribosome, and the resolution falls off only modestly toward the
lumenal end (Figure 1B). Notably, the density threshold at which
Cell 157, 1632–1643, June 19, 2014 ª2014 The Authors 1635
extensions of ribosomal proteins previouslymodeled by second-
ary structure predictions were also visible and built de novo
(Figure S4B). The ribosome stalk was stabilized in the class of
particles containing eEF2, which facilitated modeling at high
resolution in this region (Figure S4C and S4D). As a result, we
were able to build a near-complete 80S mammalian ribosome
at atomic resolution. The marked improvement in the model is
evident from the reduction of Ramachandran outliers within the
ribosomal proteins from !13% (Anger et al., 2013) to !5.4%
for the 60S subunit and !7.5% for the 40S (Table S2). The low
percentage of Ramachandran outliers suggests the quality
of our mammalian cryo-EM model is comparable to that of
the seminal S. cerevisiae ribosome crystal structure determined
to 3.0 A˚ resolution (Ben-Shem et al., 2011).
Unlike in bacteria, the eukaryotic ribosome relies on extensive
protein-protein interactions (Ben-Shem et al., 2011; Anger et al.,
2013), and the improved model presented here illustrates many
of the detailed chemical interactions that stabilize the mamma-
lian ribosome. For example, ribosomal proteins eL21 and uL30
together each contribute one strand of a b sheet, while stacking
interactions are observed between a phenylalanine in eL20 and
the 28S rRNA. Additionally, though eEF2 was bound in a non-
physiological state without P-site tRNA, its interactions with
ribosomal proteins uL10 and uL11 can be observed at high res-
olution (Figures S4C and S4D). Given the high degree of confi-
dence we now have in the model, and the extremely high
sequence conservation of the ribosome in all mammals (Table
S1), this structure will serve as a resource for future biochemical
and structural experiments.
Hybrid State tRNAs in an Actively Translating Ribosome
The translating ribosome-translocon structure contained hybrid
state A/P- and P/E-site tRNAs and a nascent polypeptide. The
conformation of the P/E tRNA is similar to earlier reports (Tour-
igny et al., 2013; Dunkle et al., 2011) and stabilizes the L1 stalk
inward. However, as previous reconstructions of an A/P tRNA
Figure 2. Representative Density for the Ri-
bosomal Proteins and rRNA
(A–D) Cryo-EM density for the 60S subunit and the
body of the 40S was sufficient to allow unambig-
uous placement of rRNA bases (A, C, D) amino
acid side chains (B, C, D), and many ions (D). Also
see Figure S4.
were limited to !9 A˚ resolution (Agirreza-
bala et al., 2008; Julia´n et al., 2008), our
structure represents the first high-resolu-
tion visualization of an A/P tRNA bound
to the ribosome (Figure 3A). Though the
sample contains a mixture of tRNA spe-
cies, it was nevertheless possible to
infer the global c nformational chang s
required to adopt this hybrid conforma-
tion (Figures 3B a d 3C).
In order t simultaneously bind the
A-site mRNA codon and the 60S P site,
the body of the tRNA must bend by !13"
when compared to a canonical A-site tRNA (Voorhees et al.,
2009). Notably, the CCA tail of the A/P tRNA does not superim-
pose with the 30 end of a canonical P-site tRNA, presumably
because in the hybrid state the 60S subunit is in a different
orientation relative to the 40S. Thus, the hybrid A/P conformation
is accomplished by an !9 A˚ displacement of the CCA tail, com-
parable to that observed in reconstructions of the bacterial com-
plex (Agrawal et al., 2000), and by bending in two regions of the
tRNA: the anticodon stem loop, and the acceptor/T-stem stack.
Similar regions have b en implicated in binding of tRNAs to the
ribosome in other noncanonical conformations (Schmeing et al.,
2009). In p r icular, mutatio s in the anticodon s em loop have
profound functional effects (Hirsh and Gold, 1971; Hirsh, 1971),
as these mutations perturb the flexibility of the tRNA body and
thus the energy required for adoption of these distorted confor-
mations (Schmeing et al., 2011, 2009). Similarly, the A/P tRNA is
undoubtedly a high-energy state stabilized by the presence of a
nascent chain, which is discussed in further detail below. The
instability of these intermediate tRNA conformations may favor
movement of tRNAs and mRNA through the ribosome, facili-
tating translocation. Thus visualization of an A/P hybrid state
further supports the notion that flexibility within the tRNA body
must be precisely tuned to the requirements of the ribosome dur-
ing protein synthesis.
Overview of the Ribosome-Sec61 Structures
In addition to the high-resolution model of the ribosome pre-
sented above, analysis of the 80S-Sec61 complex afforded
new insights into the role of Sec61 in translocation. The final
models of a porcine ribosome-Sec61 complex in both an idle
and translating state were determined to 3.4 and 3.9 A˚ resolution
(Figures 1B, S2, and S3). Local resolution analysis of a cut away
of the 60S subunit bound to Sec61 showed that the cytosolic re-
gions of the idle Sec61 complex are at a similar resolution to the
ribosome, and the resolution falls off only modestly toward the
lumenal end (Figure 1B). Notably, the density threshold at which
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the ribosome was well resolved also afforded visualization of
individual helices of the core Sec61 complex with almost no
surrounding micelle or accessory factors. At a lower threshold,
a large lumenal protrusion, which was previously identified as
the TRAP complex (Me´ne´tret et al., 2008) was observed together
with the surrounding toroidal detergent-lipid micelle. Thus, these
heterogeneous accessory components were either present at
relatively low occupancy or highly flexible, with only the Sec61
complex well ordered in nearly every particle.
All three subunits of Sec61 are present, and have been unam-
biguously built into the density, including many amino acid side
chains in the essential Sec61a and g subunits (Figure 4, Fig-
ure S5). Notably, the two ribosome-associating cytoplasmic
loops in Sec61a, between transmembrane helices 6 and 7
(loop 6/7) and transmembrane helices 8 and 9 (loop 8/9), have
been built de novo (Figures 4C and 4D), as they have changed
conformation compared to isolated crystal structures of SecY
(Van den Berg et al., 2004; Tsukazaki et al., 2008). These loops
were modeled only approximately in previous lower-resolution
studies (Park et al., 2014; Gogala et al., 2014). Density for the
nonessential Sec61b subunit is only visible in unsharpened
maps displayed at low threshold, suggesting that it may be con-
formationally heterogeneous. We have therefore modeled only
the backbone of the transmembrane helix of this subunit.
The overall architecture of the ribosome-bound mammalian
Sec61 complex is similar to previously reported structures of
the prokaryotic SecY determined by X-ray crystallography (Van
den Berg et al., 2004). Earlier moderate resolution cryo-EM
maps fit with homology models of the X-ray structures also
show the same general architecture (Park et al., 2014; Gogala
et al., 2014). However, given the significant improvement in res-
olution over these reconstructions, it is now possible to describe
the atomic interactions of Sec61 with the ribosome and the na-
ture of relatively subtle conformational changes that may occur
within Sec61 during protein translocation.
Interactions between the Ribosome and Sec61 Complex
Sec61 interacts with the ribosome primarily through the evolu-
tionarily conserved loop 6/7 and loop 8/9 in the a subunit, as
well as the N-terminal helix of Sec61g (Figures 4A and 4B). The
most extensive interaction surface is composed of loop 8/9
and Sec61g, which together contact the backbone of the 28S
rRNA and ribosomal proteins uL23 and eL29. Earlier structures
implicated Sec61 interactions with uL29 (Becker et al., 2009).
Although loop 6/7 packs against a loop of uL29, we could not
observe specific contacts.
Specific interactions involve several conserved basic residues
in loop 8/9, including His404, which interacts with Thr82 of uL23,
and the universally conserved Arg405, which forms a stacking
interaction with rRNA residue C2526 (Figure 4E). The hydroxyl
group of Thr407 in helix 10, whose role in ribosome binding
has not been previously predicted, is also within hydrogen
bonding distance of the side chain of Asn36 of eL19. This may
represent a conserved interaction, as the presence of a polar
residue at position 407 has been evolutionarily retained. Finally,
Arg20 of the g subunit forms a salt bridge with Asp148 of uL23
(Figure 4F). These hydrogen bonding interactions stabilize the
conformation of loop 8/9, and anchor the translocon at the exit
tunnel. This observation is consistent with biochemical studies,
which demonstrate that mutations to conserved residues in
this loop cause a marked decrease in affinity of the translocon
for the ribosome (Cheng et al., 2005).
Conversely, very few specific hydrogen-bonding interactions
are observed for loop 6/7. Arg273 and Lys268 interact with phos-
phate oxygens within the 28S rRNA, while Arg273 appears to
be stacking on Arg21 from protein eL39 (Figure 4G). Inverting
the charge of Arg273 causes a severe growth defect in yeast,
Figure 3. An A/P Hybrid State tRNA
(A) Overview of the hybrid A/P (purple) and P/E tRNAs (green) visualized in the
translating ribosome-Sec61 structure.
(B and C) Adoption of the hybrid A/P conformation (purple) relative to the
canonical A-site tRNA (gray) requires a !13" rotation in the backbone of
the tRNA just above the anticodon stem loop, as well as a 10" rotation in the
acceptor/T-stem stack and a 9 A˚ displacement of the 30 tail.
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the ribosome was well resolved also afforded visualization of
individual helices of the core Sec61 complex with almost no
surrounding micelle or accessory factors. At a lower threshold,
a large lumenal protrusion, which was previously identified as
the TRAP complex (Me´ne´tret et al., 2008) was observed together
with the surrounding toroidal detergent-lipid micelle. Thus, these
heterogeneous accessory components were either present at
relatively low occupancy or highly flexible, with only the Sec61
complex well ordered in nearly every particle.
All three subunits of Sec61 are present, and have been unam-
biguously built into the density, including many amino acid side
chains in the essential Sec61a and g subunits (Figure 4, Fig-
ure S5). Notably, the two ribosome-associating cytoplasmic
loops in Sec61a, between transmembrane helices 6 and 7
(loop 6/7) and transmembrane helices 8 and 9 (loop 8/9), have
been built de novo (Figures 4C and 4D), as they have changed
conformation compared to isolated crystal structures of SecY
(Van den Berg et al., 2004; Tsukazaki et al., 2008). These loops
were modeled only approximately in previous lower-resolution
studies (Park et al., 2014; Gogala et al., 2014). Density for the
nonessential Sec61b subunit is only visible in unsharpened
maps displayed at low threshold, suggesting that it may be con-
formationally heterogeneous. We have therefore modeled only
the backbone of the transmembrane helix of this subunit.
The overall architecture of the ribosome-bound mammalian
Sec61 complex is similar to previously reported structures of
the prokaryotic SecY determined by X-ray crystallography (Van
den Berg et al., 2004). Earlier moderat r solution cryo-EM
maps fit with homology models of the X-ray structures also
show the same general architecture (Park et al., 2014; Gogala
et al., 2014). However, given the significant improvement in res-
olution over these reconstructions, it is now possible to describe
the atomic int ractions of Sec61 with th ribosome and the na-
ture of relatively subtle conformational changes that may occur
within Sec61 during protein translocation.
Interactions between the Ribosome and Sec61 Complex
Sec61 interacts with the ribosome primarily through the evolu-
tionarily conserved loop 6/7 and loop 8/9 in the a subunit, as
well as the N-terminal helix of Sec61g (Figures 4A and 4B). The
most extensive interaction surface is composed of loop 8/9
and Sec61g, which together contact the backbone of the 28S
rRNA and ribosomal proteins uL23 and eL29. Earlier structures
implicated Sec61 interactions with uL29 (Becker et al., 2009).
Although loop 6/7 packs against a loop of uL29, we could not
observe specific contacts.
Specific interactions involve several conserved basic residues
in loop 8/9, including His404, which interacts with Thr82 of uL23,
and the universally conserved Arg405, which forms a stacking
interaction with rRNA residue C2526 (Figure 4E). The hydroxyl
group of Thr407 in helix 10, whose role in ribosome binding
has not been previously predicted, is also within hydrogen
bonding distance of the side chain of Asn36 of eL19. This may
represent a conserved interaction, as the presence of a polar
residue at position 407 has been evolutionarily retained. Finally,
Arg20 of the g subunit forms a salt bridge with Asp148 of uL23
(Figure 4F). These hydrogen bonding interactions stabilize the
conformation of loop 8/9, and anchor the translocon at the exit
tunnel. This observation is consistent with biochemical studies,
which demonstrate that mutations to conserved residues in
this loop cause a marked decrease in affinity of the translocon
for the ribosome (Cheng et al., 2005).
Conversely, very few specific hydrogen-bonding interactions
are observed for loop 6/7. Arg273 and Lys268 interact with phos-
phate oxygens within the 28S rRNA, while Arg273 appears to
be stacking on Arg21 from protein eL39 (Figure 4G). Inverting
the charge of Arg273 causes a severe growth defect in yeast,
Figure 3. An A/P Hybrid State tRNA
(A) Overview of the hybrid A/P (purple) and P/E tRNAs (green) visualized in the
translating ribosome-Sec61 structure.
(B and C) Adoption of the hybrid A/P conformation (purple) relative to the
canonical A-site tRNA (gray) requires a !13" rotation in the backbone of
the tRNA just above the anticodon stem loop, as well as a 10" rotation in the
acceptor/T-stem stack and a 9 A˚ displacement of the 30 tail.
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consistent with the observed interaction with the rRNA (Cheng
et al., 2005). While it is clear that loop 6/7 is playing an important
role in protein translocation due to its proximity to the ribosome,
and its sequence conservation, the relatively small number of
contacts suggest that it is unlikely to provide the primary stabili-
zation of Sec61 to the ribosome. This is supported by the obser-
vation that although mutations within loop 6/7 cause profound
defects in protein translocation and cell growth, they do not
appear to affect ribosome binding (Cheng et al., 2005).
In all of the isolated crystal structures of SecY, cytosolic loops
6/7 and 8/9 are involved in a crystal contact (Van den Berg et al.,
2004; Tsukazaki et al., 2008; Egea and Stroud, 2010) or interact
with either a Fab or SecA (Tsukazaki et al., 2008; Zimmer et al.,
2008). These loops appear to provide a flexible binding surface,
likely due to their large number of charged and polar residues,
which is exploited in both physiological and nonphysiological
interactions.
Conformation of Ribosome-Bound Sec61
It has long been predicted that ribosome binding must prime the
translocon to accept an incoming nascent chain. The idea is
attractive because the channel must prepare to open toward
the lumen or the membrane, requiring at least partial destabiliza-
tion of the contacts that prevent access to these compartments.
To gain insight into this priming reaction, we compared our idle
ribosome-Sec61 structure to previous crystal structures from
Figure 4. Interaction of Sec61 with the
Ribosome
(A) Overview of the region of the ribosome sur-
rounding the Sec61 complex, including the cyto-
solic loops 6/7 and 8/9. Sec61a is displayed in red,
g in tan, and b in light blue.
(B) Close-up of the cytosolic loops of Sec61 and
the surrounding ribosomal proteins and RNA.
(C and D) Representative density for the cytosolic
loops of Sec61a, regions of Sec61g, and their
corresponding helices.
(E) Hydrogen bonding interactions between resi-
dues H404 and R405 in loop 8/9 of Sec61a and
ribosomal protein uL23 and the 28S rRNA.
(F) Visualization of a salt bridge between R20 in the
N-terminal helix of Sec61g and D148 in yL23.
(G) An arginine stack between residue R273 in
loop 6/7 and R21 in eL39 is stabilized by interac-
tion with the backbone of the 28S rRNA.
See also Figure S5.
either archaea (Van den Berg et al.,
2004) or bacteria (Tsukazaki et al.,
2008). The implicit assumption in this
comparison (Figure 5) is that the crystal
structures approximate the preprimed
quiescent state in the membrane. With
this caveat in mind, we propose the
following hypothesis for how ribosome
binding could trigger a series of confor-
mational changes that result in Sec61
priming.
In the ribosome-bound state, loop 6/7 is displaced relative to
the isolated crystal structures, resulting in a rotation of the loop
by 20–30 degrees (Figure 5B). Were the loop to remain in the
conformation observed in the isolated structures, it would clash
with either ribosomal protein uL29 or the 28S rRNA. It is likely that
the extensive contacts between loop 8/9 and the ribosome,
along with the clash with uL29 and the rRNA, constrain loop
6/7 into the observed conformation. Similarly, loop 8/9 is shifted
by !6 A˚, and the N terminus of the gamma subunit by !3 A˚,
compared to the isolated SecY in order to interact with the 28S
rRNA and ribosomal proteins (Figure 5C).
The ribosome-constrained conformation of these loops trans-
mits a small, but concerted distortion to their adjoining helices,
which appears to be propagated helix to helix through the
Sec61 channel. As the interhelical contacts in Sec61a are likely
weakest at the lateral gate, these movements result in a slight
opening between the cytosolic halves of helices 2 and 8 (Fig-
ure 5D). For example, residues G96 and T378 move from 4.4 A˚
apart in the isolated structure, to 11 A˚ apart on the ribosome.
However, the intramembrane and lumenal portions of the lateral
gate are largely unchanged and remain closed. An earlier model
in which helix 8 bends substantially upon ribosome binding
(Gogala et al., 2014) could not be supported by our higher-reso-
lution map.
Furthermore, the plug is virtually unaltered from the conforma-
tion observed in the isolated structures (Figure 5E). The positions
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consistent with the observed interaction with the rRNA (Cheng
et al., 2005). While it is clear that loop 6/7 is playing an important
role in protein translocation due to its proximity to the ribosome,
and its sequence conservation, the relatively small number of
contacts suggest that it is unlikely to provide the primary stabili-
zation of Sec61 to the ribosome. This is supported by the obser-
vation that although mutations within loop 6/7 cause profound
defects in protein translocation and cell growth, they do not
appear to affect ribosome binding (Cheng et al., 2005).
In all of the isolated crystal structures of SecY, cytosolic loops
6/7 and 8/9 are involved in a crystal contact (Van den Berg et al.,
2004; Tsukazaki et al., 2008; Egea and Stroud, 2010) or interact
with either a Fab or SecA (Tsukazaki et al., 2008; Zimmer et al.,
2008). These loops appear to provide a flexible binding surface,
likely due to their large number of charged and polar residues,
which is exploited in both physiological and nonphysiological
interactions.
Conformation of Ribosome-Bound Sec61
It has long been predicted that ribosome binding must prime the
translocon to accept an incoming nascent chain. The idea is
attractive because the channel must prepare to open toward
the lumen or the membrane, requiring at least partial destabiliza-
tion of the contacts that prevent access to these compartments.
To gain insight into this priming reaction, we compared our idle
ribosome-Sec61 structure to previous crystal structures from
Figure 4. Interaction of Sec61 with the
Ribosome
(A) Overview of the region of the ribosome sur-
rounding the Sec61 complex, including the cyto-
solic loops 6/7 and 8/9. Sec61a is displayed in red,
g in tan, and b in light blue.
(B) Close-up of the cytosolic loops of Sec61 and
the surrounding ribosomal proteins and RNA.
(C and D) Representative density for the cytosolic
loops of Sec61a, regions of Sec61g, and their
corresponding helices.
(E) Hydrogen bonding interactions between resi-
dues H404 and R405 in loop 8/9 of Sec61a and
ribosomal protein uL23 and the 28S rRNA.
(F) Visualization of a salt bridge between R20 in the
N-terminal helix of Sec61g and D148 in yL23.
(G) An arginine stack between residue R273 in
loop 6/7 and R21 in eL39 is stabilized by interac-
tion with the backbone of the 28S rRNA.
See also Figure S5.
either archaea (Van den Berg et al.,
2004) or bacteri (Tsukazaki et al.,
2008). The implici a sumption in this
comparison (Figure 5) is that the crystal
ructures approxim te th pr primed
quiescent state in he membrane. With
this caveat in mind, we propos the
following hypothesis for how ribosome
binding could trigger a series of confor-
matio al changes that result in Sec61
priming.
In the ribosome-bound state, loop 6/7 is displaced relative to
the isolated crystal structures, resulting in a rotation of the loop
by 20–30 degrees (Figure 5B). Were the loop to remain in the
conformation observed in the isolated structures, it would clash
with either ribosomal protein uL29 or the 28S rRNA. It is likely that
the extensive contacts between loop 8/9 and the ribosome,
along with the clash with uL29 and the rRNA, constrain loop
6/7 into the observed conformation. Similarly, loop 8/9 is shifted
by !6 A˚, and the N terminus of the gamma subunit by !3 A˚,
compared to the isolated SecY in order to interact with the 28S
rRNA and ribosomal proteins (Figure 5C).
The ribosome-constrained conformation of these loops trans-
mits a small, but concerted distortion to their adjoining helices,
which appears to be propagated helix to helix through the
Sec61 channel. As the interhelical contacts in Sec61a are likely
weakest at the lateral gate, these movements result in a slight
opening between the cytosolic halves of helices 2 and 8 (Fig-
ure 5D). For example, residues G96 and T378 move from 4.4 A˚
apart in the isolated structure, to 11 A˚ apart on the ribosome.
However, the intramembrane and lumenal portions of the lateral
gat are largely unchang d and remain closed. An earlier model
in which helix 8 bends substantially upon ribosome binding
(Gogala et al., 2014) could not be supported by our higher-reso-
lution map.
Furthermore, the plug is virtually unaltered from the conforma-
tion observed in the isolated structures (Figure 5E). The positions
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of helices surrounding the plug, which contribute pore-ring resi-
dues, also remain essentially unchanged. This suggests that the
overall stability of the plug is not markedly altered by ribosome
binding, although it is possible subtle differences in pore-ring
interactions partially destabilize this region.
In total, these conformational changes may represent the
priming of Sec61 upon binding of the ribosome. Though we
cannot exclude the possibility that these movements are the
result of sequence differences between archaea and mammals,
this seems unlikely given the high degree of sequence conserva-
tion in the regions interacting with the ribosome and the interhel-
ical contacts that change upon priming. Relative to the isolated
crystal structures, the primed Sec61 has prepared for protein
translocation by decreasing the activation energy required to
open the lateral gate without altering the conformation or stability
of the plug. Since targeting to the Sec61 complex is mediated
by either a signal peptide or transmembrane domain, a cytosoli-
cally cracked lateral gate is ideally positioned to receive these
forthcoming hydrophobic elements from SRP.
Indeed, a transmembrane domain stalled at a preinsertion
state site specifically crosslinks to residues lining the cytosolic
region of the lateral gate (Mackinnon et al., 2014). Insertion of a
signal peptide or transmembrane domain into this site would
further open the lateral gate, presumably destabilizing the plug.
In this way, the channel’s opening toward the lumen would be
coupled to successful recognition of a bona fide substrate.
Figure 5. Conformation of Ribosome-
Bound Sec61a
(A) Overview of the lateral gate of the ribosome-
bound Sec61a in red, compared to the isolated
crystal structure of the archaeal SecY in gray (Park
et al., 2014).
(B) Cytosolic loop 6/7 shifts by 11 A˚ relative to the
the archaeal SecY structure.
(C) Cytosolic loop 8/9 shifts by 6 A˚ relative to the
bacterial SecY structure shown in pink (Tsukazaki
et al., 2008). The bacterial structure is used for
comparison here because loop 8/9 is disordered in
the archaeal structure.
(D) Close-up of the lateral gate (helices 2 and 3
with helices 7 and 8), highlighting the opening of
the cytosolic region between helices 8 and 2 in the
ribosome-bound state.
(E) Close-up of the plug region, which is unaltered
in the ribosome-bound state.
(F) Comparison of the lateral gate in the Sec61-
ribosome structure relative to that observed
in the SecY-SecA complex (light blue; Zimmer
et al., 2008).
Interestingly, movements of the lateral
gate in Sec61, as described here, closely
resemble those that occur upon binding
of another translocation partner, SecA,
to the cytosolic face of SecY (Figure 5F).
As with the ribosome, SecA interactions
with the cytosolic loops 6/7 and 8/9 also
partially separate helix 8 and 2 at the
lateral gate (Zimmer et al., 2008). These
conformational changes may thus represent a universal mecha-
nism for preparing the channel for translocation. However, the
movements in the lateral gate with SecA are more exaggerated
than with the ribosome: helix 7 shifts to increase the extent of
lateral gate opening, while the plug is displaced toward the peri-
plasm. Snapshots of the lateral gate and plug in a more open or
closed form are also seen when SecY interacts with either an
adjacent proteinmolecule (Egea andStroud, 2010) or a Fab (Tsu-
kazaki et al., 2008), respectively. Thus, the lateral gate interface
would appear to be rather pliable and easily modulated by any
number of physiologic or artificial interactions, particularly with
the cytosolic loops.
The Nascent Peptide in the Ribosomal Tunnel
Though the translationally active ribosome-Sec61 structure con-
tains a heterogeneous mixture of translating polypeptides, it was
possible to visualize near-continuous density in the ribosomal
exit tunnel beginning at the tRNA and approaching the translo-
con (Figure 6A). No density in the exit tunnel was observed in
the population of ribosomeswithout tRNAs. Through themajority
of the tunnel, the observed density would be most consistent
with an extended polypeptide chain. However, within the wider
region of the ribosomal tunnel near the exit site, the density for
the peptide broadens, suggesting that alpha-helix formation
may be possible. As our sample contains an ensemble average
of nascent chains, representing endogenous polypeptides, it
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of helices surrounding the plug, which contribute pore-ring resi-
dues, also remain essentially unchanged. This suggests that the
overall stability of he plug is not markedly altered by ribosom
binding, although it is possible subtle differences in pore-ring
interactions partially destabilize this region.
In total, these onformational changes may represent the
priming of Sec61 upon binding of th riboso e. Though we
cannot exclude the possibility that these movements are the
result of sequence differences between archaea and mammals,
this seems unlikely given the high degr e of sequence con erva-
tion in the regions interacting with the ribosome and the interhel-
ical contacts that change upon priming. Relative to the isolated
crystal structures, the primed Sec61 has prepared for protein
translocation by decreasing the activation energy required to
open the lateral gate without altering the conformation or stability
of the plug. Since targeting to the Sec61 complex is mediated
by either a signal peptide or transmembrane domain, a cytosoli-
cally cracked lateral gate is ideally positioned to receive these
forthcoming hydrophobic elements from SRP.
Indeed, a transmembrane domain stalled at a preinsertion
state site specifically crosslinks to residues lining the cytosolic
region of the lateral gate (Mackinnon et al., 2014). Insertion of a
signal peptide or transmembrane domain into this site would
further open the lateral gate, presumably destabilizing the plug.
In this way, the channel’s opening toward the lumen would be
coupled to successful recognition of a bona fide substrate.
Figure 5. Conformation of Ribosome-
Bound Sec61a
(A) Overview of the lateral gate of the ribosome-
bound Sec61a in red, compared to the isolated
crystal structure of the archaeal SecY in gray (Park
et l., 2014).
(B) Cytosolic loop 6/7 shifts by 11 A˚ relative to the
the archaeal SecY structure.
(C) Cytosoli loop 8/9 shifts by 6 A˚ relative to the
bacterial SecY structure shown in pink (Tsukazaki
et al., 2008). The bacterial structure is used for
comparison here because loop 8/9 is disordered in
the archaeal structure.
(D) Close-up of the lateral gate (helices 2 and 3
with helices 7 and 8), highlighting the opening of
the cy osolic gion between h lices 8 and 2 in the
ribosome-bound state.
(E) Close-up of the plug region, which is unaltered
in the ribosome-bound state.
(F) Comparison of the lateral gate in the Sec61-
ribo ome structure relative to that observed
in th SecY-Se A compl x (light blue; Zimmer
et al., 2008).
Interestingly, movements of the lateral
gate in Sec61, as described here, closely
resemble those that occur upon binding
of another translocation partner, SecA,
to the cytosolic face of SecY (Figure 5F).
As with the riboso e, S cA interactions
with the cytosolic loops 6/7 and 8/9 also
partially separate helix 8 and 2 at the
lateral gate (Zi mer et al., 2008). These
conformational changes may thus represent a universal mecha-
nism for preparing the channel for translocation. However, the
movements in the lateral gate with SecA are more exaggerated
than with the ribosome: helix 7 shifts to increase the extent of
lateral gate opening, while the plug is displaced toward the peri-
plasm. Snapshots of t e lateral gate nd plug in a more open or
closed form are also seen when SecY interacts with either an
adjacent proteinmolecule (Egea andStroud, 2010) or a Fab (Tsu-
kazaki et al., 2008), respectively. Thus, the lateral gate interface
would appear to be rath r pliable and easily modulated by any
number of physiologic or artificial interactions, particularly with
the cytosolic loops.
The Nascent Peptide in the Ribosomal Tunnel
Though the translationally active ribosome-Sec61 structure con-
tains a heterogeneous mixture of translating polypeptides, it was
possible to visualize near-continuous density in the ribosomal
exit tunnel beginning at the tRNA and approaching the translo-
con (Figure 6A). No density in the exit tunnel was observed in
the population of ribosomeswithout tRNAs. Through themajority
of the tunnel, the observed density would be most consistent
with an extended polypeptide chain. However, within the wider
region of the ribosomal tunnel near the exit site, the density for
the peptide broadens, suggesting that alpha-helix formation
may be possible. As our sample contains an ensemble average
of nascent chains, representing endogenous polypeptides, it
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suggests that all peptides follow a universal path through the
ribosome, regardless of sequence or secondary structure
tendency.
The density for the peptide first encounters Sec61 adjacent to
loop 6/7, providing further evidence for the critical role this loop
plays in protein translocation (Raden et al., 2000; Cheng et al.,
2005). Several studies have hypothesized that there may be
communication between the ribosomal tunnel and translocon
to potentially prepare the channel for the handling of specific
upcoming sequence domains (Berndt et al., 2009; Liao et al.,
1997; Pool, 2009). As the rRNA lining the tunnel is relatively
fixed, it has been proposed that such communication would
involve the ribosomal proteins. The only protein that directly
contacts Sec61 and partially lines the tunnel is eL39, which is
positioned at the distal region of the tunnel (Figures 6A and
6B), where the peptide could begin to adopt secondary struc-
ture features. It is plausible that the conformation or hydropho-
bicity of the nascent peptide chain can be communicated via
eL39 directly to loop 6/7 of the translocon (Figure 6B; see Fig-
ure 4G for detail). Alternatively, this communication could be
transmitted via uL23, which forms extensive interactions with
both eL39 and Sec61 at the surface of the ribosome (Figure 6B).
The ability to visualize at near-atomic resolution both a defined
nascent polypeptide and the Sec61-interacting ribosomal pro-
teins surrounding the exit tunnel should allow these hypotheses
to be directly tested.
Structure of the Translating Ribosome-Sec61 Complex
Given the presence of the hybrid state tRNAs and nascent pep-
tide, this class of particles clearly contains an actively translating
ribosome-translocon complex. However, at a threshold at
which nascent chain density is visible in the ribosomal tunnel,
density was not observed within the Sec61 channel. One reason
may be that upon exit from the ribosome, nascent chains have
more conformational freedom inside a dynamic Sec61 than
within the ribosomal tunnel. We cannot exclude the alternative
possibility that nascent chains have slipped out of the Sec61
pore during sample preparation.
However, several lines of evidence suggest that most
translating ribosome-Sec61 complexes in our sample contain a
nascent chain within the Sec61 channel. First, the majority of
polypeptides in this sample represent soluble proteins of at least
!150 residues (Figure S1), a length more than sufficient to span
the aligned conduits of the ribosome and Sec61 channel. Sec-
ond, folded lumenal domains in most of these nascent chains
would prevent back sliding through the pore during solubili-
zation. Third, solubilization of pancreatic microsomes under
conditions comparable to those used here retain nearly all
endogenous nascent chains within the translocon (Matlack and
Walter, 1995). Fourth, sample preparation after solubilization
was very brief (<30 min) with minimal manipulations (Figures
S1C and S1D), in contrast to the multistep purification that re-
sulted in partial loss of nascent chains (Park et al., 2014). For
these reasons, we provisionally interpret this structure as an
‘‘active’’ Sec61 channel in the discussion below; definitive proof
must await a structure that permits direct nascent chain visuali-
zation. Though the resolution of this active Sec61 channel struc-
ture inmany regions does not allow the same type of atomic level
analysis as is possible for the idle translocon, it is still feasible to
examine its main characteristics (Figures S6A and S6B).
In agreement with earlier studies (Gogala et al., 2014), the
translocating state of Sec61 has no large-scale changes in its
architecture (Figure 6C). Helices 2, 7, and 8 do not appear to
have undergone substantial rearrangement, and the lateral
gate is largely unchanged from the primed state. Additionally,
helices 1 and 10 have shifted (Figure 6C), and the density for helix
3 is very weak (Figure S6A), suggesting it has becomemobile. At
a threshold where all the surrounding helices were visualized,
density for the plug was no longer visible in the center of the
channel (Figure 6D) and a continuous conduit now runs through
Figure 6. The Translating Ribosome-Sec61 Complex
(A) Cryo-EM density within the ribosomal exit tunnel for the nascent peptide
(cyan), which spans from the A/P tRNA to Sec61. The location of ribosomal
protein eL39, which lines the exit tunnel, is indicated.
(B) Ribosomal protein eL39 (bright blue) forms part of the exit tunnel (high-
lighted in cyan) and interacts with loop 6/7 of Sec61. Ribosomal protein uL23
(dark blue) contacts both eL39 and loop 8/9 of Sec61.
(C) Comparison of the Sec61 channel structures bound to idle or translating
ribosome, showing movements in helices 1 and 10, which may be important
for allowing translocation of the nascent polypeptide. Also see Figure S6.
(D) Rigid-body fitting of the idle Sec61 model (red) into the density for the
translating Sec61-ribosome complex demonstrates that the plug is not visible
in its canonical location. Displayed is an unsharpened map in which the
disordered density for the detergent micelle has been removed using Chimera
(Goddard et al., 2007).
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suggests that all peptides follow a universal path through the
ribosome, regardless of sequence or secondary structure
tendency.
The density for the peptide first encounters Sec61 adjacent to
loop 6/7, providing further evidence for the critical role this loop
plays in protein translocation (Raden et al., 2000; Cheng et al.,
2005). Several studies have hypothesized that there may be
communication between the ribosomal tunnel and translocon
to potentially prepare the channel for the handling of specific
upcoming sequence domains (Berndt et al., 2009; Liao et al.,
1997; Pool, 2009). As the rRNA lining the tunnel is relatively
fixed, it has been proposed that such communication would
involve the ribosomal proteins. The only protein that directly
contacts Sec61 and partially lines the tunnel is eL39, which is
positioned at the distal region of the tunnel (Figures 6A and
6B), where the peptide could begin to adopt secondary struc-
ture features. It is plausible that the conformation or hydropho-
bicity of the nascent peptide chain can be communicated via
eL39 directly to loop 6/7 of the translocon (Figure 6B; see Fig-
ure 4G for detail). Alternatively, this communication could be
transmitted via uL23, which forms extensive interactions with
both eL39 nd Sec61 at the s rface of the ribosome (Figure 6B).
The ability to visualize at near-atomic resolution both a defined
nascent polypeptide and the Sec61-interacting ribosomal pro-
teins surrounding the exit tunnel should allow these hypotheses
to be directly tested.
Structure of the Translating Ribosome-Sec61 Complex
Given the presence of he hybrid state tRNAs and nascent pep-
tide, this class of particles clearly contains an actively translating
ribosome-translocon complex. However, at a threshold at
which nascent chain nsity is visibl in the ribosomal tunnel,
density was not observed within the Sec61 ch nnel. One reason
may be that upon exit from the ribosome, nascent chains have
more conformational freedom inside a dynamic Sec61 than
within the ribosomal tunnel. We cannot exclude the alternative
possibility that nascent chains have slipped out of the Sec61
pore during sample preparation.
However, several lines of evidence suggest that most
translati ribosome-Sec61 complexes in our sampl contain a
nascent chain within the Sec61 chann l. First, th majority of
polypeptide in this sample repre ent s luble proteins f at least
!150 residues (Figure S1), a length more than sufficient to span
the aligned conduits of the ribosome and Sec61 channel. Sec-
ond, folded lumenal domains in most of these nascent chains
would prevent back sliding through the pore during solubili-
zation. Third, solubilization of pancreatic microsomes under
conditions comparable to those used here retain nearly all
endogenous nascent chains within the translocon (Matlack and
Walter, 1995). Fourth, sample preparation after solubilization
was very brief (<30 min) with minimal manipulations (Figures
S1C and S1D), in contrast to the multistep purification that re-
sulted in partial loss of nascent chains (Park et al., 2014). For
these reasons, we provisionally interpret this structure as an
‘‘active’’ Sec61 channel in the discussion below; definitive proof
must await a structure that permits direct nascent chain visuali-
zation. Though the resolution of this active Sec61 channel struc-
ture inmany regions does not allow the same type of atomic level
analysis as is possible for the idle translocon, it is still feasible to
examine its main characteristics (Figures S6A and S6B).
In agreement with earlier studies (Gogala et al., 2014), the
translocating state of Sec61 has no large-scale changes in its
architecture (Figure 6C). Helices 2, 7, and 8 do not appear to
have undergone substantial rearrangement, and the lateral
gate is largely unchanged from the primed state. Additionally,
helices 1 and 10 have shifted (Figure 6C), and the density for helix
3 is very weak (Figure S6A), suggesting it has becomemobile. At
a threshold where all the surrounding helices were visualized,
density for the plug was no longer visible in the center of the
channel (Figure 6D) and a continuous conduit now runs through
Figure 6. The Translating Ribosome-Sec61 Complex
(A) Cryo-EM density within the ribosomal exit tunnel for the nascent peptide
(cyan), which spans from the A/P tRNA to Sec61. The location of ribosomal
protein eL39, which lines the exit tunnel, is indicated.
(B) Ribosomal protein eL39 (bright blue) forms part of the exit tunnel (high-
lighted in cyan) and interacts with loop 6/7 of Sec61. Ribosomal protein uL23
(dark blue) contacts both eL39 and loop 8/9 of Sec61.
(C) Comparison of the Sec61 channel structures bound to idle or translating
ribosome, showing movements in helices 1 and 10, which may be important
for allowing translocation of the nascent polypeptide. Also see Figure S6.
(D) Rigid-body fitting of the idle Sec61 model (red) into the density for the
translating Sec61-ribosome complex demonstrates that the plug is not visible
in its canonical location. Displayed is an unsharpened map in which the
disordered density for the detergent micelle has been removed using Chimera
(Goddard et al., 2007).
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Sec61a. The central pore was sufficiently large to house a model
of an extended polypeptide without clashes.
While the plug’s canonical position was not occupied in the
active state, we could not unambiguously assign it to an alternate
location. It is possible the plug adopts a variety of conformations
in this sample (given the heterogeneous sequences of translo-
cating nascent chains) or becomes disordered to allow translo-
cation. Given that the plug can be crosslinked to several dispa-
rate residues within an active SecY, it is likely dynamic once
freed from its interactions with the pore ring. This flexibility may
be facilitated by the observed movements in helix 1. In the static
situation of a stalled nascent chain (Gogala et al., 2014), the plug
may settle at its lowest energy state, perhaps explaining why it
was apparently seen near its original location. However steric
constraints would require at least a nominal shift in the plug to
accommodate the nascent peptide within the central pore.
Although fewer particles for the active Sec61 complex led to a
lower-resolution map than that for the idle complex, some areas
are better resolved than others (Figures S6A and S6B). Helices 6-
9, along with loops 6/7 and 8/9, display the highest resolution
within the structure as judged by atomic B-factor (Figure S6C).
This provides confidence in concluding that this part of Sec61
has few if any substantive conformational changes relative to
the idle state. Thus, the C-terminal half of Sec61 effectively forms
a stable platform for ribosome interaction.
By contrast, the density for helices 2-4 is significantly weaker
than for either this same region in the idle Sec61 structure, or for
helices 6-9 in the active structure (Figure S6). This observation
strongly argues that the position of helices 2-4 in the active
Sec61 is heterogeneous. Several nonmutually exclusive expla-
nations are possible: (i) heterogeneous clients at different stages
of transloction; (ii) different accessory proteins acting during
translocation; and (iii) inherent flexibility in this region when the
plug is displaced. Irrespective of the specific explanation (s), it
would seem clear that helices 6-9 provide a ribosome-stabilized
fulcrum, which allowsmovements within the remaining portion of
the molecule to accommodate the nascent chain.
Implications for Cotranslational Protein Translocation
The structures described here help refine our understanding
of several steps during cotranslational protein translocation
and provide mechanistic insights into the two stages for fully
activating the Sec61 channel (Figure 7). In the quiescent state
presumably represented by the isolated crystal structure (Van
den Berg et al., 2004), the channel is fully closed to both the
lumen and lipid bilayer. The first stage of activation involves
binding of the ribosome, which primes the channel by opening
of the cytosolic side of the lateral gate, thereby decreasing the
energetic barrier for translocation. The movement of helix 2,
implicated as part of this priming reaction, may provide a hydro-
phobic docking site for the arriving signal peptide in this region.
Importantly, this primed state leaves the channel largely closed
to membrane and entirely closed to the ER lumen.
In the second stage of activation, a suitable substrate can now
exploit the primed Sec61 by binding to and further opening the
lateral gate. Signal peptide engagement at the lateral gate results
in destabilization of the plug from the pore ring, either by steri-
cally pushing the plug out of position, or by opening of the lateral
gate, which shifts the helices surrounding the plug. Such a state
appears to have been captured at low resolution in the E. coli
system (Park et al., 2014). This model would rationalize why pro-
miscuously targeted nonclients are rejected by Sec61, prior to
gaining access to the lumenal environment (Jungnickel and
Rapoport, 1995). The model would also explain how a small
molecule that seems to bind near the plug can allosterically
inhibit a signal sequence from successfully engaging Sec61
(Mackinnon et al., 2014).
Once the plug is destabilized, the translocating nascent chain
can enter the channel, which sterically prevents the plug from
adopting its steady-state conformation.Adynamicplugno longer
stabilizes the surrounding helices at the central pore, permitting
a more dynamic lateral gate. This flexibility may permit sampling
of the lipid bilayer by the translocating nascent chain, thereby al-
lowing suitably hydrophobic elements to insert in the membrane.
This model for activation provides one explanation for why trans-
membrane segments within a multispanning membrane protein
can be far less hydrophobic than those that engage the Sec61
channel de novo: the latter would need to fully open a nearly-
closed lateral gate stabilized by the plug, while the former could
take advantage of a gate made dynamic by plug displacement.
Both before and during translocation, a constant feature of
the native ribosome-translocon complex is the substantial gap
cytosol
lumen
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Figure 7. A Two-Step Model for Activation
of Sec61
Displayed here is a cut-away view of the model for
the Sec channel from the central pore toward the
lateral gate (dashed line). In the quiescent state
(left), approximated by a crystal structure of the
archaeal SecY complex (Van den Berg et al.,
2004), the Sec channel is closed to both the lumen
and lipid bilayer. The channel becomes primed
for protein translocation upon ribosome binding
(middle), triggering conformational changes in
Sec61 that crack the cytosolic side of the lateral
gate (demarcated by an asterisk). The movements
of helices 2 and 3 in this region may create an
initial binding site for signal peptide recognition.
Engagement of the lateral gate by the signal peptide would open the channel toward themembrane and initiate translocation (not depicted; Park et al., 2014). The
translocating state of the active ribosome-Sec61 complex (right) contains a nascent polypeptide (teal) and is characterized by a dynamic plug domain and an
open conduit between the cytosol and lumen (teal dotted line).
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Structures of the bacterial ribosome have provided a framework for understanding universal
mechanisms of protein synthesis. However, the eukaryotic ribosome is much larger than it is
in bacteria, and its activity is fundamentally different inmany keyways. Recent cryo-electron
microscopy reconstructions and X-ray crystal structures of eukaryotic ribosomes and ribo-
somal subunits now provide an unprecedented opportunity to explore mechanisms
of eukaryotic translation and its regulation in atomic detail. This review describes the
X-ray crystal structures of the Tetrahymena thermophila 40S and 60S subunits and the
Saccharomyces cerevisiae 80S ribosome, as well as cryo-electron microscopy reconstruc-
tions of translating yeast and plant 80S ribosomes.Mechanistic questions about translation in
eukaryotes that will require additional structural insights to be resolved are also presented.
All ribosomes are composed of two subunits,both of which are built from RNA and pro-
tein (Figs. 1 and 2). Bacterial ribosomes, for
example of Escherichia coli, contain a small sub-
unit (SSU) composed of one 16S ribosomal
RNA (rRNA) and 21 ribosomal proteins (r-pro-
teins) (Figs. 1A and 1B) and a large subunit
(LSU) containing 5S and 23S rRNAs and 33
r-proteins (Fig. 2A). Crystal structures of pro-
karyotic ribosomal particles, namely, the Ther-
mus thermophilus SSU (Schluenzen et al. 2000;
Wimberly et al. 2000), Haloarcula marismortui
and Deinococcus radiodurans LSU (Ban et al.
2000; Harms et al. 2001), and E. coli and
T. thermophilus 70S ribosomes (Yusupov et al.
2001; Schuwirth et al. 2005; Selmer et al. 2006),
reveal the complex architecture that derives
from the network of interactions connecting
the individual r-proteins with each other and
with the rRNAs (Brodersen et al. 2002; Klein
et al. 2004). The 16S rRNA can be divided
into four domains, which together with the r-
proteins constitute the structural landmarks of
the SSU (Wimberly et al. 2000) (Fig. 1A): The 50
and 30 minor (h44) domains with proteins S4,
S5, S12, S16, S17, and S20 constitute the body
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Figure 1. The bacterial and eukaryotic small ribosomal subunit. (A,B) Interface (upper) and solvent (lower)
views of the bacterial 30S subunit (Jenner et al. 2010a). (A) 16S rRNAdomains and associated r-proteins colored
distinctly: b, body (blue); h, head (red); pt, platform (green); and h44, helix 44 (yellow). (B) 16S rRNA colored
gray and r-proteins colored distinctly and labeled. (C–E) Interface and solvent views of the eukaryotic 40S
subunit (Rabl et al. 2011), with (C) eukaryotic-specific r-proteins (red) and rRNA (pink) shown relative to
conserved rRNA (gray) and r-proteins (blue), and with (D,E) 18S rRNA colored gray and r-proteins colored
distinctly and labeled.
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Figure 1. The bacterial and eukaryotic small ribosomal subunit. (A,B) Interface (upper) and solvent (lower)
views of the bacterial 30S subunit (Jenner et al. 2010a). (A) 16S rRNAdomains and associated r-proteins colored
distinctly: b, body (blue); h, head (red); pt, platform (green); and h44, helix 44 (yellow). (B) 16S rRNA colored
gray and r-proteins colored distinctly and labeled. (C–E) Interface and solvent views of the eukaryotic 40S
subunit (Rabl et al. 2011), with (C) eukaryotic-specific r-proteins (red) and rRNA (pink) shown relative to
conserved rRNA (gray) and r-proteins (blue), and with (D,E) 18S rRNA colored gray and r-proteins colored
distinctly and labeled.
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Figure 2.The bacterial and eukaryotic large ribosomal subunit. (A) Interface (upper) and solvent (lower) views of
the bacterial 50S subunit (Jenner et al. 2010b), with 23S rRNA domains and bacterial-specific (light blue) and
conserved (blue) r-proteins colored distinctly: cp, central protuberance; L1, L1 stalk; and St, L7/L12 stalk (or P-
stalk in archeaa/eukaryotes). (B–E) Interface and solvent views of the eukaryotic 60S subunit (Klinge et al.
2011), with (B) eukaryotic-specific r-proteins (red) and rRNA (pink) shown relative to conserved rRNA (gray)
and r-proteins (blue), (C) eukaryotic-specific expansion segments (ES) colored distinctly, and (D,E) 28S rRNA
colored gray and r-proteins colored distinctly and labeled.
Structure and Function of Eukaryotic Ribosome
Cite this article as Cold Spring Harb Perspect Biol 2012;4:a011536 3
Cold Spring Harbor Laboratory Press 
 at Cold Spring Harbor Laboratory Library on October 26, 2014 - Published byhttp://cshperspectives.cshlp.org/Downloaded from 
S7e
ES6se
L32e
L1
L1
cp
L7
L5 L5
L16 L16
L27P-tRNAP-tRNA
mRNA
S30e
S3
S5
S4
S17e
S5
S28e
S26e
S3RACK1
S28e
3′end 18S
S26e
pt
bk
h
b
S19 S13
S11
S1e
S7
S25e
S31e
S30e
A site
S12
P site E site
cp
L28e
L4
ES6sa
ES6sb
ES3sb
ES39L
ES7Lb
ES7Lc ES7La
L4
L30
A
C
F G
D E
B
L7
L13
L33e
L14e
ES3sa
bk
h
pt
b
S8e
S6e
S4e
Figure 3. Structural and functional aspects of the eukaryotic ribosome. Interweaving of rRNA and r-proteins
on the (A) LSU near ES7L and ES39L (Klinge et al. 2011), and (B) SSU near ES3 and ES6 (Rabl et al. 2011).
Extension of r-proteins at the tRNA-binding sites on the (C) SSU (Armache et al. 2010b; Rabl et al. 2011), LSU
of the (D) bacterial (Jenner et al. 2010b), and (E) eukaryotic (Armache et al. 2010b) peptidyltransferase centers.
R-proteins located at the mRNA (F) exit, and (G) entry sites (Klinge et al. 2011).
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Figure 2. Defects in the Signal Sequence or in a Targeting Factor, SRP, Lead to Decreased Levels of a Secretory Protein mRNA
(A and B) Effect of deletions in signal sequence on PPL mRNA levels. PPL and control mRNAs were analyzed by northern blot (A) or qPCR (B; n = 9, mean ± SD)
42 hr after transfection of HeLa Tet-On with WT and mutated PPL plasmids.
(C) Presence of a mutated PPL signal sequence (PPL-D4L) in hybrid proteins containing the mature part of a1-antitrypsin (AT) or carbonic anhydrase IV (CA4) is
sufficient to trigger mRNA depletion. mRNA levels measured by qPCR (n = 3, mean ± SD) are shown relatively to mRNA levels of corresponding hybrid proteins
containing WT PPL signal sequence (PPL-WT).
(D) Deletions (indicated by dashes) in the natural signal sequences of secretory proteins AT or CA4.
(E) Deletions in the hydrophobic core of natural signal sequences of AT or CA4 proteins lead to a decrease in their mRNA levels. Graph shows mRNA levels
measured by qPCR (n = 3, mean ± SD).
(F) Scheme shows differences in biogenesis of secretory and cytosolic proteins. When the signal sequence of a secretory protein emerges from the ribosomal
tunnel it is recognized by SRP, and the complex is targeted to SRP receptor and finally to a translocon in ER membrane. Nascent chains of cytosolic proteins do
not have signal sequences, however, their nascent chains are recognized by ribosome-associated chaperones and that help them fold in the cytosol.
(G and H) SRP depletion causes a reduction in the level of secretory protein mRNA. Detection of PPL, and actin mRNAs (northern blot), SRP54, PPL and actin
proteins (western blot) in HeLa Tet-On cells transfected with siRNA for SRP54 andWT orD4L PPL plasmids as indicated (G). Quantification ofWT PPL (open bars)
or D4L mutant (black bars) mRNAs by qPCR in independent sets of SRP54 knockdown experiments (n = 3, mean ± SD) (H).
(I) Knockdown of SRP receptor subunits SRa and SRb, or translocon component, Sec61a, does not affect PPL mRNA level (qPCR, n = 3, mean ± SD). WT PPL
(open bars), D4L mutant (black bars).
(legend continued on next page)
148 Cell 156, 146–157, January 16, 2014 ª2014 Elsevier Inc.
Inefficient SRP Interaction with a
Nascent Chain Triggers a mRNA
Quality Control Pathway
Andrey L. Karamyshev,1,* Anna E. Patrick,1,9 Zemfira N. Karamysheva,1 Dustin S. Griesemer,1,10 Henry Hudson,1
Sandra Tjon-Kon-Sang,1 IngMarie Nilsson,3 Hendrik Otto,5 Qinghua Liu,2 Sabine Rospert,5 Gunnar von Heijne,3,4
Arthur E. Johnson,6,7,8 and Philip J. Thomas1,*
1Department of Physiology
2Department of Biochemistry
UT Southwestern Medical Center at Dallas, Dallas, TX 75390, USA
3Center for Biomembrane Research, Department of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden
4Science for Life Laboratory Stockholm University, Box 1031, 171 21 Solna, Sweden
5Institute of Biochemistry and Molecular Biology, ZBMZ, and BIOSS Centre for Biological Signalling Studies, University of Freiburg,
79104 Freiburg, Germany
6Department of Molecular and Cellular Medicine, Texas A&M Health Science Center
7Department of Biochemistry and Biophysics
8Department of Chemistry
Texas A&M University, College Station, TX 77843, USA
9Present address: Vanderbilt University School of Medicine, Nashville, TN 37232, USA
10Present address: Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
*Correspondence: andrey.karamyshev@utsouthwestern.edu (A.L.K.), philip.thomas@utsouthwestern.edu (P.J.T.)
http://dx.doi.org/10.1016/j.cell.2013.12.017
SUMMARY
Misfolded proteins are often cytotoxic, unless
cellular systems prevent their accumulation. Data
presented here uncover a mechanism by which de-
fects in secretory proteins lead to a dramatic reduc-
tion in their mRNAs and protein expression. When
mutant signal sequences fail to bind to the signal
recognition particle (SRP) at the ribosome exit site,
the nascent chain instead contacts Argonaute2
(Ago2), and the mutant mRNAs are specifically
degraded. Severity of signal sequence mutations
correlated with increased proximity of Ago2 to
nascent chain and mRNA degradation. Ago2 knock-
down inhibited degradation of the mutant mRNA,
while overexpression of Ago2 or knockdown of
SRP54 promoted degradation of secretory protein
mRNA. The results reveal a previously unappreciated
general mechanism of translational quality control, in
which specific mRNA degradation preemptively
regulates aberrant protein production (RAPP).
INTRODUCTION
The cytotoxicity of misfolded and mistargeted proteins is coun-
tered by cellular systems that prevent their accumulation (Stefani
and Dobson, 2003). Cells have strict quality-control systems in
the cytosol and in the endoplasmic reticulum (ER) to distinguish
properly folded proteins from misfolded (Buchberger et al.,
2010; Ellgaard and Helenius, 2003). Secretory and membrane
proteins that are not transported to their proper cellular destina-
tions are either degraded by the ER associated degradation
(ERAD) pathway (Brodsky, 2012; Smith et al., 2011) or form inclu-
sions (Kopito, 2000). When proteins are successfully translo-
cated from the cytosol to the ER, but are not transported further
due to misfolding in stress conditions, the unfolded protein
response (UPR) is activated. UPR involves activation of stress
response genes, general downregulation of protein synthesis,
and degradation of misfolded ER proteins (Schro¨der and Kauf-
man, 2005; Walter and Ron, 2011). Another mechanism that
prevents accumulation of misfolded proteins in the ER during
UPR is regulated ire1-dependent decay (RIDD) (Hollien et al.,
2009; Hollien andWeissman, 2006). This mechanism is activated
under conditions of general ER stress and reduces the quantity
of many mRNAs that encode secretory proteins. Thus, these
processes are general responses to stress conditions and
have not evolved to specifically triage an individual mutant pro-
tein that misfolds. Whether cells can specifically prevent the syn-
thesis of ‘‘unwanted,’’ and potentially hazardous proteins
derived from mutated or foreign mRNAs is only poorly under-
stood. If mutant proteins do not fold properly or fail to be deliv-
ered to the appropriate cellular compartment, they can be
removed by the proteasome system (Ward et al., 1995). Such a
posttranslational mechanism, however, does not prevent
continued de novo production of the mutant gene product.
Currently known systems of mRNA quality control, nonsense
mediated decay (NMD), nonstop decay (NSD), and no-go decay
(NGD), detect only profound defects, including premature stop
codons, lack of a natural stop codon, or stalled ribosomes
(Doma and Parker, 2007; Shoemaker and Green, 2012). These
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between Lys29 and Gln15 of Naa10p and Asp532 and Gln491 of 
Naa15p. Single point mutations in this region did not break up the 
complex and had only modest effects on substrate binding and cataly-
sis (Table 2), probably owing to the extensiveness of the interface. 
A smaller hydrophobic interface is formed between Naa10p His20 
and Naa15p Phe449 and Trp494 and is supplemented with a hydro-
gen bond between Naa10p Gln25 and Naa15p Arg448. This region 
of Naa15p directly stabilizes the position of the Naa10p A1 helix as 
well as the Naa10p A1–A2 loop and as a result is crucial for proper 
complex formation. This is evident from the observation that alanine 
point mutations at either Naa15p Arg448 or Naa15p Phe449 were 
able to disrupt NatA complex formation. Several additional scattered 
intermolecular interactions serve to supplement the Naa10p-Naa15p 
interface (Supplementary Fig. 3).
Molecular basis for Naa15p modulation of Naa10p acetylation
To explore the molecular basis for Naa15p modulation of Naa10p 
acetyltransferase activity, we determined the X-ray crystal structure of 
Naa10p of S. pombe in the absence of Naa15p, for comparison with the 
holo-NatA complex (Table 1). We determined the structure of Naa10p 
(residues 1–156) to 2.00-Å resolution, using a combination of single- 
wavelength anomalous diffraction and molecular replacement (model, 
NAA50) to phase data collected on a selenomethionine-derivatized 
Naa10p protein. An alignment of the complexed and uncomplexed 
forms of Naa10p revealed that the A1–loop–A2 segment assumes 
a substantially different conformation in the presence of Naa15p 
(Fig. 2a). Notably, this conformational change is driven by the move-
ment of several hydrophobic residues in Naa10p A2 (Leu28, Leu32 
and Ile36), which make intramolecular interactions with residues in 
Naa10p A1 and B3 (Ile8, Leu11, Met14, Tyr55 and Tyr57) in apo-
Naa10p but shift to make alternative intermolecular interactions 
with helices of Naa15p in the NatA complex (Figs. 1c and 2b). As 
a result of this interaction, the C-terminal region of the A1 helix 
undergoes an additional helical turn, which helps to reposition the 
A1–A2 loop. Notably, docking of the apo-Naa10p structure into the 
corresponding binding pocket of Naa15p showed a clash between the 
Naa10p A1–loop–A2 and Naa15p Arg448 and Naa15p Phe449 of A25 
(Fig. 2c)—the same interface that we have shown to be necessary for 
proper complex formation (Fig. 1d and Table 2).
As a result of the Naa15p interaction along one side of the Naa10p 
A1–loop–A2 region, residues on the opposite side of this loop region 
appear to adopt a specific conformation that is essential for catalysis 
of traditional substrates (alanine, cysteine, glycine, serine, threonine 
or valine) (Supplementary Videos 2 and 3). Specifically, Naa10p 
residues Leu22 and Tyr26 shift about 5.0 Å from surface-exposed 
positions to buried positions in the active site, and Naa10p Glu24 
moves by about 4.0 Å, substantially altering the landscape of the NatA 
active site (Fig. 2d). All of these residues are well ordered in both 
structures (Supplementary Fig. 4). Our comparison of the com-
plexed and uncomplexed structures suggests that the auxiliary subunit 
induces an allosteric change in the Naa10p active site to an extent that 
is required for the mechanism of catalysis by the NatA complex, and 
Naa10p is likely to represent an active GNAT fold. Consistent with 
this hypothesis, a backbone alignment of key active site elements in 
active Naa10p with the corresponding region in the independently 
active human NAA50 that selects a 1-Met-Leu-2 N-terminal sequence 
shows a high degree of structural conservation (r.m.s. deviation of 
1.52 Å). The corresponding alignment of the complexed and uncom-
plexed forms of Naa10p showed less structural conservation, with an 
r.m.s. deviation of 2.43 Å (Fig. 2e).
Substrate peptide binding and NatA inhibition
To determine the molecular basis for substrate-specific peptide bind-
ing by NatA, and in particular how, unlike most other NATs, it is able 
to accommodate a number of nonmethionine N-terminal substrates, 
we synthesized a bisubstrate conjugate in which CoA is covalently 
linked to a biologically relevant substrate peptide fragment with the 
sequence 1-SASEA-5 (CoA-SASEA). We performed inhibition stud-
ies with CoA-SASEA and with a control compound, acetonyl CoA, 
which is a nonhydrolyzable acetyl CoA analog (Fig. 3a). Half-maxi-
mum inhibitory concentration (IC50) determinations revealed that 
CoA-SASEA had an IC50 of 1.4 o 1.0 MM, whereas acetonyl CoA 
had an IC50 of 380 o 10 MM (Fig. 3b). To assess the specificity of this 
inhibitor toward NatA, we also calculated IC50 values of CoA-SASEA 
and acetonyl CoA with NAA50, a NAT that requires a substrate 
N-terminal methionine residue. We found that CoA-SASEA has an 
IC50 of 11 o 2 MM, whereas acetonyl CoA has an IC50 of 130 o 12 MM 
(Fig. 3b). With NAA50, the addition of a SASEA peptide portion 
was able to increase the potency of acetonyl CoA by only about ten-
fold, whereas with NatA this peptide addition exhibited an increase 
in potency of about 300-fold. The greater potency of acetonyl CoA 
with NAA50 over Naa10p can be explained by the stronger binding of 
acetyl CoA to NAA50 (Km = 27 o 2 MM) than to Naa10p (Km = 59 o 
5 MM). The markedly higher potency of the CoA-SASEA inhibitor 
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Figure 1 Overall structure of the NatA complex bound to acetyl CoA. (a) Naa10p (teal) and Naa15p (brown) subunits, shown in cartoon, bound to 
acetyl CoA (CPK coloring and stick format). Only Naa15p helices that contact Naa10p are labeled. The dashed brown line represents a disordered 
loop region in Naa15p. The dimensions of the complex are 107 Å × 85 Å × 70 Å. (b) A 90° rotation of the view in a. Helices that are depicted in c and 
d are labeled. (c) Zoom view highlighting key residues that compose the predominantly hydrophobic interface between Naa10p A1–A2 and Naa15p 
A29–A30. (d) Zoom view of the intersubunit interface at the C-terminal region of Naa10p A1 and the Naa15p A25–A27–A28 helices.
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Chemical Approaches for the Detection and Synthesis of
Acetylated Proteins
Yu-Ying Yang and Howard C. Hang*[a]
Introduction
Protein acetylation describes the covalent modification of pro-
tein with an acetyl group (Scheme 1). Acetylation can modu-
late protein–protein interactions, protein stability and signal
transduction in cells to regulate physiological responses and
disease progression. Amongst the different types of protein
acetylation, lysine acetylation has emerged as a major post-
translational modification (PTM) in both eukaryotes and prokar-
yotes (Scheme 1A). Notably, reversible lysine acetylation of his-
tones enables epigenetic regulation of gene expression in eu-
karyotes.[1–3] The recent discovery of many other lysine-acety-
lated proteins by mass spectrometry (MS) suggests lysine ace-
tylation is involved in diverse functions in cells.[4–6] MS-based
proteomics has also revealed thousands of proteins bearing N-
terminal acetylation that might serve as a key mechanism for
controlling protein stability in eukaryotes (Scheme 1B).[7–9] In
addition, acetylation of serine and threonine residues has been
discovered in eukaryotic proteins in the context of bacterial in-
fection in which secretion of bacterial acetyltransferases into
host cells modulates inflammatory responses (Scheme 1C).[10,11]
Given the prevalence and diversity of protein acetylation,
robust methods are needed for the detection and synthesis of
acetylated proteins to unravel
their biological functions and
underlying regulatory mecha-
nisms. Herein, we survey recent
chemical approaches to monitor
and discover acetylated proteins
as well as semisynthetic meth-
ods to produce homogeneously
acetylated proteins.
Lysine Acetylation
Lysine acetylation is a reversible
PTM that is tightly regulated by
lysine acetyltransferases (KATs)[12]
and lysine deacetylases
(KDACs)[13] in both prokaryotic
and eukaryotic cells
(Scheme 1A). As a highly dynam-
ic modification like phosphoryla-
tion, lysine acetylation can regu-
late protein functions by two
major mechanisms. Firstly, acety-
lation results in neutralization of
the positive charge on lysine res-
idues that can alter protein
structure, folding, and interac-
tion with other proteins. Second-
ly, acetyllysine can serve as a recognition motif to interact with
bromodomain-containing proteins[14,15] or other proteins that
can specifically recognize acetyllysine residues[16] to recruit pro-
tein complexes for downstream signaling functions. Lysine ace-
tylation was initially identified on histones by Allfrey and co-
workers in 1964.[17] Histone acetylation typically results in a
more relaxed chromatin structure and permissive environment
for access of transcription factors to activate gene expression
Scheme 1. Different classes of protein acetylation. A) Lysine acetylation is a reversible PTM that is tightly regulated
by KATs and KDACs. Propionylation and butyrylation have also been described on lysine residues. B) N-terminal
acetylation is regulated by N-acetyltransferases. C) Serine and threonine acetylation are executed by secreted bac-
terial effector proteins during infection of eukaryotic cells.
[a] Dr. Y.-Y. Yang, Prof. H. C. Hang
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The Rockefeller University
1230 York Avenue, New York, NY 10065 (USA)
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NatA	  (Naa10/Naa15)	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NatA function 
•  generation and differentiation of neurons 
•  β-Catenin transcriptional activity 
•  cyclin D1 regulation 
•  NF- κB /DNA-damage response pathways 
•  cellular hypoxia 
•   apoptosis & cancer  
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between Lys29 and Gln15 of Naa10p and Asp532 and Gln491 of 
Naa15p. Single point mutations in this region did not break up the 
complex and had only modest effects on substrate binding and cataly-
sis (Table 2), probably owing to the extensiveness of the interface. 
A smaller hydrophobic interface is formed between Naa10p His20 
and Naa15p Phe449 and Trp494 and is supplemented with a hydro-
gen bond between Naa10p Gln25 and Naa15p Arg448. This region 
of Naa15p directly stabilizes the position of the Naa10p A1 helix as 
well as the Naa10p A1–A2 loop and as a result is crucial for proper 
complex formation. This is evident from the observation that alanine 
point mutations at either Naa15p Arg448 or Naa15p Phe449 were 
able to disrupt NatA complex formation. Several additional scattered 
intermolecular interactions serve to supplement the Naa10p-Naa15p 
interface (Supplementary Fig. 3).
Molecular basis for Naa15p modulation of Naa10p acetylation
To explore the molecular basis for Naa15p modulation of Naa10p 
acetyltransferase activity, we determined the X-ray crystal structure of 
Naa10p of S. pombe in the absence of Naa15p, for comparison with the 
holo-NatA complex (Table 1). We determined the structure of Naa10p 
(residues 1–156) to 2.00-Å resolution, using a combination of single- 
wavelength anomalous diffraction and molecular replacement (model, 
NAA50) to phase data collected on a selenomethionine-derivatized 
Naa10p protein. An alignment of the complexed and uncomplexed 
forms of Naa10p revealed that the A1–loop–A2 segment assumes 
a substantially different conformation in the presence of Naa15p 
(Fig. 2a). Notably, this conformational change is driven by the move-
ment of several hydrophobic residues in Naa10p A2 (Leu28, Leu32 
and Ile36), which make intramolecular interactions with residues in 
Naa10p A1 and B3 (Ile8, Leu11, Met14, Tyr55 and Tyr57) in apo-
Naa10p but shift to make alternative intermolecular interactions 
with helices of Naa15p in the NatA complex (Figs. 1c and 2b). As 
a result of this interaction, the C-terminal region of the A1 helix 
undergoes an additional helical turn, which helps to reposition the 
A1–A2 loop. Notably, docking of the apo-Naa10p structure into the 
corresponding binding pocket of Naa15p showed a clash between the 
Naa10p A1–loop–A2 and Naa15p Arg448 and Naa15p Phe449 of A25 
(Fig. 2c)—the same interface that we have shown to be necessary for 
proper complex formation (Fig. 1d and Table 2).
As a result of the Naa15p interaction along one side of the Naa10p 
A1–loop–A2 region, residues on the opposite side of this loop region 
appear to adopt a specific conformation that is essential for catalysis 
of traditional substrates (alanine, cysteine, glycine, serine, threonine 
or valine) (Supplementary Videos 2 and 3). Specifically, Naa10p 
residues Leu22 and Tyr26 shift about 5.0 Å from surface-exposed 
positions to buried positions in the active site, and Naa10p Glu24 
moves by about 4.0 Å, substantially altering the landscape of the NatA 
active site (Fig. 2d). All of these residues are well ordered in both 
structures (Supplementary Fig. 4). Our comparison of the com-
plexed and uncomplexed structures suggests that the auxiliary subunit 
induces an allosteric change in the Naa10p active site to an extent that 
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and C).3 There are no substantial interactions beyond the leu-
cine backbone carbonyl group seen in the structure. The overall
thermal B-factor of the peptide is 73.9, which is high in relation
to the overall thermal B-factor of the protein, 55. This discrep-
ancy can be accounted for by the skewed nature of theB-factors
of the individual residues of the peptide. Met1 has a B-factor of
62, and this value increases for each residue of the peptide that
extends out of the binding pocket, with the Pro4B-factor reach-
ing 93. For comparison, the atoms of CoA have an average
B-factor of 50. Superposition of the ternary complex with the
binary Naa50p!acetyl-CoA complex (Protein Data Bank code
2OB0) showed no significant structural rearrangement upon
substrate peptide binding (supplemental Fig. 1), further reveal-
ing that Naa50p does not undergo significant structural change
upon protein substrate binding.
The Naa50p Protein Substrate-binding Site Is Ideally Suited
to Accommodate an !-Amino Group of an N-terminal
Methionine—The N-terminal peptide substrate points into the
protein active site, with the backbone roughly perpendicular to
the central "-sheet and parallel to the pantothenate arm of the
CoA (Figs. 1B and 2A). The peptide is anchored to the protein
through a series of hydrogen bonds between the side chains of
Tyr-31 and Tyr-139 and the backbone carbonyl atoms of
Met-75 and His-112 (Fig. 2C). The N-terminal methionine sits
in a hydrophobic pocket composed of Phe-27, Pro-28, and
Val-29 from the !1-!2 loop and Tyr-139 and Ile-142 from the
"6-"7 hairpin loop, which each make van der Waals contacts
withMet1 of the peptide. Leu2 also sits in a hydrophobic pocket
formed by Tyr-31 and Phe-35 from the !1-!2 loop segment,
Tyr-138 from the "6-"7 hairpin loop, and Tyr-73 and Met-75
from the "4 strand (Fig. 2C). There are also hydrophilic groups
in the vicinity of Leu2 such as the hydroxyls of Tyr-73 and Tyr-
138 and the guanidinium group of Arg-62 (Fig. 2C), which pro-
vides an explanation for the ability of Naa50p to acetylate a
substrate with a hydrophilic residue at the second position.
Consistent with the importance of residues that contact the
peptide, each of these residues is highly conserved within the
Naa50p orthologs from other species (Fig. 2D). In particular,
the residues that contact the peptide backbone (Tyr-31, Met-
75, His-112, and Tyr-139) and Met1 (Phe-27, Pro-28, Val-29,
Tyr-139, and Ile-142) are strictly conserved, and residues that
contact Leu2 (Tyr-31, Phe-35, Tyr-73, Met-75, and Tyr-138)
are strictly or highly conserved (Fig. 2D).
To establish directly the functional importance of Naa50p
residues that appear to make important peptide substrate con-
tacts in the crystal structure, we targeted several of these resi-
dues for mutagenesis, followed by enzymatic characterization
of the mutant proteins. Each mutated residue was changed to
alanine, and the catalytic efficiency of each mutant was deter-
mined and compared with that of the wild-type protein. Each
mutantwas purified to homogeneity and exhibited gel filtration
chromatography elution profiles identical to that of the wild-
type construct. To confirm further that the mutant proteins
were folded properly, they were subjected to circular dichroism
experiments, each revealing a similar spectrum to thewild-type
protein (data not shown). Notably, each of the mutant proteins
showed defects in catalytic efficiency, with most of the mutant
proteins showing no detectable activity (Fig. 3 and Table 2). Of
the residues that contact the peptide backbone, Tyr-31, His-
112, and Tyr-139 were mutated, and each of these mutants
showed no detectable activity, arguing for the importance of
these residues for backbone interaction, although Tyr-31 also
participates in Leu2 peptide contact, and His-112 likely partic-
ipates directly in catalysis, as will be described below (Fig. 3 and
Table 2). Of the residues that contact Met1 of the peptide, the
Phe-27 mutant showed no detectable activity, whereas the
Pro-28 andVal-29mutants showed at least an 85% reduction in
activity. The Tyr-139 mutant showed no detectable activity,
and the Ile-142mutant retained!40% activity (Fig. 3 andTable
2). Mutants of Leu2 peptide contact residues Tyr-31, Phe-35,
andTyr-73 each showed no detectable activity (Fig. 3 andTable
2). Taken together, the results from the structure-based
mutagenesis are consistent with the functional importance of
the protein-peptide substrate interactions observed in the crys-
tal structure.
Tyr-73 and His-112 Likely Play Catalytic Roles through an
Ordered Water Molecule—Analysis of the Naa50p active site
revealed that only two residues are in position to function in
3 The positions of residues in the peptide substrate are indicated by super-
script numbers, and those in the protein enzyme are indicated by hyphen-
ated full-size numbers.
FIGURE 1.Overall structure of the ternary Naa50p!CoA!peptide complex.
A, structure of the ternary complex showing Naa50p in teal; CoA asmagenta
stickswith carbon, nitrogen, and sulfur atoms in Corey-Pauling-Koltun color-
ing; and the substrate peptide as yellow sticks with carbon, nitrogen, and
sulfur atoms in Corey-Pauling-Koltun coloring. Substrate peptide electron
density obtained from a composite omit map (blue) is shown contoured to
1.5#. B, superposition of the ternary Naa50p complex with the ternary Gcn5
HAT. The Gcn5 enzyme and accompanying substrate peptide (orange) are
shown in schematic format. The substrate peptides for each enzyme are
shown as thicker schematics for clarity.
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Background: The human Na 50p N-termi l acetyltransferase acetylates proteins on the !-amino group of methionine
residues to regulate genome integrity and has elevated activity in cancer.
Results:We report the structure of the Naa50p"CoA"peptide complex and related biochemistry.
Conclusion:We reveal the molecular basis for substrate-specific acetylation by Naa50p.
Significance: We provide a molecular scaffold for the design of Naa50p-specific inhibitors with possible therapeutic
application .
The co-translational modification of N-terminal acetylation
is ubiquitous among eukaryotes and has been reported to have a
wide range of biological effects. The human N-terminal acetyl-
transferase (NAT)Naa50p (NAT5/SAN) acetylates the!-amino
group of proteins containing an N-terminal methionine residue
and is essential f r proper sister chromatid cohesio and chro-
mosome condensation. The elevated activity of NATs has also
been correlated with cancer, making these enzymes attractive
therapeutic targets. We report the x-ray crystal structure of
Naa50p bound to a native substrate peptide fragment and CoA.
We found that thepeptidebackboneof the substrate is anchored
to theprotein through a series of backbonehydrogenbondswith
the first methionine residue specified through multiple van der
Waals contacts, together creating an !-amino methionine-spe-
cific pocket. We also employed structure-based mutagenesis;
the results support the importance of the !-amino methionine-
specific pocket of Naa50p and are consist nt with the proposal
that conserved histidine and tyrosine residues play important
catalytic roles. Superposition of the te nary Naa50p complex
with the peptide-boundGcn5histone acetyltransferase revealed
that the two enzymes share a Gcn5-related N-acetyltransferase
fold but differ in th r respective subs rate-binding grooves such
that Naa50p can accommodate only an !-amino substrate and
not a side chain lysine substrate that is acetylated by lysine
acetyltransferase enzymes such as Gcn5. The structure of the
ternary Naa50p complex also provides the first molecular
scaffold for the design of NAT-specific small molecule inhibi-
tors with possible therapeutic applications.
Protein acetylation is one of the most common covalent
modifications found in the proteome (1). In this process, an
acetyl group is transferred from acetyl-CoA to an !-amino
group at the N terminus of a protein or an "-amino group on a
lysine side chain. Lysine acetyltransferase enzymes have been
more extensively characterized than N- erminal acetyltrans-
ferase (NAT)2 enzymes at the biochemical, enzymological, and
structural levels (2). To date, only one structure of a prokaryotic
NAT has been reported (3), and the mechanisms of substrate-
specific recognition and catalysis used by th se enzymes remain
poorly understood.
In eukaryotes, N-terminal acetylation displays a wide range
of functional effects varying on a case-by-case basis (4).
Rece tly, thismodificationwas shown to serve as a degradation
signal for individu l proteins (5) and also to prevent proper
post-translational translocation through the endoplasmic
reticulum (6). I euk ryotes, multiple protei complexes are
capable of performing N-terminal ace ylation, the most pro-
miscuous an well characterized of whi h is the NatA complex
(7–9). This protein complex contains two catalytic subunits,
Naa10p (ARD1) and Naa50p, and two auxiliary subunits,
Naa15p (NATH (N-acetyltransferase human)) and HYPK,
which associate with the ribosome (9–11). The human and
fruit fly Naa50p enzymes are essential for normal sister chro-
matid cohesion and chromosome condensation, but the NatA
complex was not implicated in this phenotype, suggesting that
this is attributed solely byNaa50p-mediatedNATactivity inde-
pendent of the complex (12–14). However, the responsible sub-
strate potentially requiring N-terminal acetylation for proper
functioning remains to be identified. Interestingly, NatA sub-
units have been shown to be overexpressed in a number of
* Thisworkwas supported, inwholeor inpart, byNational Institutes ofHealth
Grant GM060293 (to R. M.) and Training Grant GM071339 (to G. L.). This
work was also supported by the Research Council of Norway and the Nor-
wegian Cancer Society (to T. A.).
□S The on-line version of this article (available at http://www.jbc.org) contains
supplemental Fig. 1.
Theatomic coordinates and structure factors (code 3TFY) havebeendeposited in
the Protein Data Bank, Research Collaboratory for Structural Bioinformatics,
Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
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miscuous and well characterized of which is the NatA complex
(7–9). This protein complex contains two catalytic subunits,
Naa10p (ARD1) and Naa50p, and two auxiliary subunits,
Naa15p (NATH (N-acetyltransferase human)) and HYPK,
which associate with the ribosome (9–11). The human and
fruit fly Naa50p enzymes are essential for normal sister chro-
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complex was not implicated in this phenotype, suggesting that
this is attributed solely byNaa50p-mediatedNATactivity inde-
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between Lys29 and Gln15 of Naa10p and Asp532 and Gln491 of 
Naa15p. Single point mutations in this region did not break up the 
complex and had only modest effects on substrate binding and cataly-
sis (Table 2), probably owing to the extensiveness of the interface. 
A smaller hydrophobic interface is formed between Naa10p His20 
and Naa15p Phe449 and Trp494 and is supplemented with a hydro-
gen bond between Naa10p Gln25 and Naa15p Arg448. This region 
of Naa15p directly stabilizes the position of the Naa10p A1 helix as 
well as the Naa10p A1–A2 loop and as a result is crucial for proper 
complex formation. This is evident from the observation that alanine 
point mutations at either Naa15p Arg448 or Naa15p Phe449 were 
able to disrupt NatA complex formation. Several additional scattered 
intermolecular interactions serve to supplement the Naa10p-Naa15p 
interface (Supplementary Fig. 3).
Molecular basis for Naa15p modulation of Naa10p acetylation
To explore the molecular basis for Naa15p modulation of Naa10p 
acetyltransferase activity, we determined the X-ray crystal structure of 
Naa10p of S. pombe in the absence of Naa15p, for comparison with the 
holo-NatA complex (Table 1). We determined the structure of Naa10p 
(residues 1–156) to 2.00-Å resolution, using a combination of single- 
wavelength anomalous diffraction and molecular replacement (model, 
NAA50) to phase data collected on a selenomethionine-derivatized 
Naa10p protein. An alignment of the complexed and uncomplexed 
forms of Naa10p revealed that the A1–loop–A2 segment assumes 
a substantially different conformation in the presence of Naa15p 
(Fig. 2a). Notably, this conformational change is driven by the move-
ment of several hydrophobic residues in Naa10p A2 (Leu28, Leu32 
and Ile36), which make intramolecular interactions with residues in 
Naa10p A1 and B3 (Ile8, Leu11, Met14, Tyr55 and Tyr57) in apo-
Naa10p but shift to make alternative intermolecular interactions 
with helices of Naa15p in the NatA complex (Figs. 1c and 2b). As 
a result of this interaction, the C-terminal region of the A1 helix 
undergoes an additional helical turn, which helps to reposition the 
A1–A2 loop. Notably, docking of the apo-Naa10p structure into the 
corresponding binding pocket of Naa15p showed a clash between the 
Naa10p A1–loop–A2 and Naa15p Arg448 and Naa15p Phe449 of A25 
(Fig. 2c)—the same interface that we have shown to be necessary for 
proper complex formation (Fig. 1d and Table 2).
As a result of the Naa15p interaction along one side of the Naa10p 
A1–loop–A2 region, residues on the opposite side of this loop region 
appear to adopt a specific conformation that is essential for catalysis 
of traditional substrates (alanine, cysteine, glycine, serine, threonine 
or valine) (Supplementary Videos 2 and 3). Specifically, Naa10p 
residues Leu22 and Tyr26 shift about 5.0 Å from surface-exposed 
positions to buried positions in the active site, and Naa10p Glu24 
moves by about 4.0 Å, substantially altering the landscape of the NatA 
active site (Fig. 2d). All of these residues are well ordered in both 
structures (Supplementary Fig. 4). Our comparison of the com-
plexed and uncomplexed structures suggests that the auxiliary subunit 
induces an allosteric change in the Naa10p active site to an extent that 
is required for the mechanism of catalysis by the NatA complex, and 
Naa10p is likely to represent an active GNAT fold. Consistent with 
this hypothesis, a backbone alignment of key active site elements in 
active Naa10p with the corresponding region in the independently 
active human NAA50 that selects a 1-Met-Leu-2 N-terminal sequence 
shows a high degree of structural conservation (r.m.s. deviation of 
1.52 Å). The corresponding alignment of the complexed and uncom-
plexed forms of Naa10p showed less structural conservation, with an 
r.m.s. deviation of 2.43 Å (Fig. 2e).
Substrate peptide binding and NatA inhibition
To determine the molecular basis for substrate-specific peptide bind-
ing by NatA, and in particular how, unlike most other NATs, it is able 
to accommodate a number of nonmethionine N-terminal substrates, 
we synthesized a bisubstrate conjugate in which CoA is covalently 
linked to a biologically relevant substrate peptide fragment with the 
sequence 1-SASEA-5 (CoA-SASEA). We performed inhibition stud-
ies with CoA-SASEA and with a control compound, acetonyl CoA, 
which is a nonhydrolyzable acetyl CoA analog (Fig. 3a). Half-maxi-
mum inhibitory concentration (IC50) determinations revealed that 
CoA-SASEA had an IC50 of 1.4 o 1.0 MM, whereas acetonyl CoA 
had an IC50 of 380 o 10 MM (Fig. 3b). To assess the specificity of this 
inhibitor toward NatA, we also calculated IC50 values of CoA-SASEA 
and acetonyl CoA with NAA50, a NAT that requires a substrate 
N-terminal methionine residue. We found that CoA-SASEA has an 
IC50 of 11 o 2 MM, whereas acetonyl CoA has an IC50 of 130 o 12 MM 
(Fig. 3b). With NAA50, the addition of a SASEA peptide portion 
was able to increase the potency of acetonyl CoA by only about ten-
fold, whereas with NatA this peptide addition exhibited an increase 
in potency of about 300-fold. The greater potency of acetonyl CoA 
with NAA50 over Naa10p can be explained by the stronger binding of 
acetyl CoA to NAA50 (Km = 27 o 2 MM) than to Naa10p (Km = 59 o 
5 MM). The markedly higher potency of the CoA-SASEA inhibitor 
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Figure 1 Overall structure of the NatA complex bound to acetyl CoA. (a) Naa10p (teal) and Naa15p (brown) subunits, shown in cartoon, bound to 
acetyl CoA (CPK coloring and stick format). Only Naa15p helices that contact Naa10p are labeled. The dashed brown line represents a disordered 
loop region in Naa15p. The dimensions of the complex are 107 Å × 85 Å × 70 Å. (b) A 90° rotation of the view in a. Helices that are depicted in c and 
d are labeled. (c) Zoom view highlighting key residues that compose the predominantly hydrophobic interface between Naa10p A1–A2 and Naa15p 
A29–A30. (d) Zoom view of the intersubunit interface at the C-terminal region of Naa10p A1 and the Naa15p A25–A27–A28 helices.
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The cotranslational process of N-terminal acetylation occurs on ~85% 
of human proteins and ~50% of yeast proteins and mediates a wide 
range of biological processes including cellular apoptosis, enzyme 
regulation, protein localization and the N-end rule for protein degra-
dation1–6. At least three NAT complexes that perform this modifica-
tion, NatA, NatB and NatC, exist as heterodimers with one unique 
catalytic subunit and an additional unique auxiliary subunit that both 
activates the enzymatic component and anchors the complex to the 
ribosome during translation7–13. Aberrant expression of the proteins 
that make up t e atA complex has been observed in a number of 
cance -cell tissues; c nsequent , AT enzymes are emerging targets 
for chemotherapeutic development14–21.
The three NAT complexes are highly conserved in eukaryotes 
from yeast to humans and are differentiated from one another on the 
basis of their substrate specificities1,5,22–24. NatA, which is composed 
of the catalytic NAA10 subu it and the auxiliary NAA15 subunit, is 
the most promiscuous of all NAT enzymes; classically, it acetylates an 
A-amino group on nascent peptide chains with an N-terminal alanine, 
cysteine, glycine, serine, threonine or valine residue1,22,24,25. Notably, 
recent studies demonstrate that NAA10 also exists as a monomer 
in cells and that it can acetylate the A-amino group of substrates 
with N-terminal aspartate and glutamate residues that can be gen-
erated post-translationally, but it will not acetylate traditional 
NatA substrates26. The NatB and NatC complexes acetylate the 
N termini of proteins with an N-terminal methionine with further 
specificity dependent upon the identity of the second residue13,23,25,27. 
Although NATs as well as many other lysine side chain acetyl-
transferases require binding partners for optimal catalytic activity, 
no acetyltransferase has been structurally characterized in the 
presence of its activating partner28–30.
Three additional NAT enzymes, NatD–NatF, have been identified 
and appear to be independently active. They also have a more limited 
set of biologically relevant substrates and are not well characterized 
across eukaryotes31–35. Currently, there is no structure of a NAT 
complex or any of the integral subunits, and the mechanism of sub-
strate-specific catalytic regulation by the auxiliary subunits remains 
uncharacterized. The only eukaryotic NAT for which structural data 
is av ilable is the human NatE (NAA50) enzyme, which is independ-
ently active an  has only o e known biologically elevant substrate; 
this substrate, containing a 1-MLGP-4 N-t rminal sequence, was 
present in an X-ray crystal structure1,36.
In this study we set out to determine the molecular basis for sub-
strate binding, acetylation specificity and mode of catalysis of the 
N tA complex and to determine the role of the auxiliary subunit in 
these activities. Toward this goal, we determined the X-ray crystal 
structures of the holo-NatA complex bound to acetyl CoA and a 
bisubstrate inhibitor, determined the structure of the Naa10p sub-
unit bound to acetyl CoA in its uncomplexed form that preferentially 
acetylates a unique subset of substrates, and carried out structure-
guided mutational analysis to derive structure-function correlations 
underlying NatA acetylation.
RESULTS
Overall structure of NatA
In an attempt to prepare the NatA complex for X-ray 
structure determination, we overexpressed the human complex 
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Molecular basis for N-terminal acetylation by the 
heterodimeric NatA complex
Glen Liszczak1,2, Jacob M Goldberg2, Håvard Foyn3, E James Petersson2, Thomas Arnesen3,4 &  
Ronen Marmorstein1,2
N-terminal acetylation is ubiquitous among eukaryotic proteins and controls a myriad of biological processes. Of the N-terminal 
acetyltransferases (NATs) that facilitate this cotranslational modification, the heterodimeric NatA complex has the most diversity 
for substrate selection and modifies the majority of all N-terminally acetylated proteins. Here, we report the X-ray crystal 
structure of the 100-kDa holo-NatA complex from Schizosaccharomyces pombe, in the absence and presence of a bisubstrate 
peptide-CoA–conjugate inhibitor, as well as the structure of the uncomplexed Naa10p catalytic subunit. The NatA-Naa15p 
auxiliary subunit contains 13 tetratricopeptide motifs and adopts a ring-like topology that wraps around the NatA-Naa10p 
subunit, an interaction that alters the Naa10p active site for substrate-specific acetylation. These studies have implications  
for understanding the mechanistic details of other NAT complexes and how regulatory subunits modulate the activity of the 
broader family of protein acetyltransferases.
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5 x 106 HEK293 cells were seeded in 10 cm dish and transfected after 24 h with 
pcDNA3.1 V5/His hNaa10 wt, pcDNA3.1 V5/His hNaa10 S37P or corresponding 
empty vector. Cells were lysed after 48 h in 500 µl lysis buffer (0.2 % Triton 
X-100, 0.1 % DTT and 1 x Complete protease inhibitor cocktail in PBS) per dish 
and cellular debris was pelleted at 20,800 g for 10 min. The lysates were pooled 
and protein concentration was determined using APA protein assay 
(Cytoskeleton).  
For IP, 40 mg total protein were incubated with 400 µl anti-V5-coupled magnetic 
beads (Invitrogen) for 2 h at 4°C under constant agitation. Beads were washed 3 
times with lysis buffer, 1 x with PBS and once with 50 % PBS. Proteins were 
digested with trypsin off the beads and labelled with distinct isobaric iTRAQ 
reagents. The samples were combined and subjected to standard 2D MudPIT 
LCMS and analyzed using a Thermo Velos Orbitrap mass spectrometer. Peptides 
were fragmented using the high-energy collision (HCD) cell to avoid low-mass 
ejection of iTRAQ reporter ions. The effects of compression of iTRAQ ratio values 
were procedurally minimized by using narrow precursor selection tolerances 
(1.2Da) and optimized settings for HCD collision energy and transmission 
efficiency. iTRAQ labeled peptides remain isobaric in MS but following HCD the 
iTRAQ reporter ions appear as distinct ions in the range 113 to 121 m/z in each 
MS/MS spectrum. The relative abundance of the peptides (and thus 
corresponding proteins) were deduced directly from the relative intensities of the 
corresponding reporter ions. Peak lists were extracted from instrument raw data 
files using the MASCOT Distiller software (MatrixScience) and the MASCOT 
searches were performed on a 64-processor cluster (Perkins et al. 1999). False 
discovery rates (FDR) were estimated by searching equivalent reversed or 
randomized sequence databases, typically using a cutoff value of 1% FDR. 
Protein-abundance ratios were calculated using intensity weighted averages from 
matching peptides after outlier removal. The relative enrichment in the samples 
were calculated as a ratio of the intensities between the samples and the 
empty-vector control. The whole experiment was done twice. 
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wt S37P
1 RPLP1* 60S acidic ribosomal protein P1 30.3 23.7
2 RPS25* 40S ribosomal protein S25 29.4 18.1
3 NACA Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Fragment) 27.5 11.0
4 HYPK Huntingtin-interacting protein K 27.0 4.3
5 RPL38* 60S ribosomal protein L38 26.8 18.3
6 RPL8* 60S ribosomal protein L8 24.7 14.4
7 RPS13* 40S ribosomal protein S13 24.1 13.5
8 RPS28* 40S ribosomal protein S28 23.8 14.6
9 FAU* 40S ribosomal protein S30 23.7 15.9
10 RPL27A* 60S ribosomal protein L27a 21.9 11.9
11 RPL6* 60S ribosomal protein L6 21.8 13.7
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Interplay between trigger factor and other protein
biogenesis factors on the ribosome
Thomas Bornemann1, Wolf Holtkamp1 & Wolfgang Wintermeyer1
Nascent proteins emerging from translating ribosomes in bacteria are screened by a number
of ribosome-associated protein biogenesis factors, among them the chaperone trigger factor
(TF), the signal recognition particle (SRP) that targets ribosomes synthesizing membrane
proteins to the membrane and the modifying enzymes, peptide deformylase (PDF) and
methionine aminopeptidase (MAP). Here, we examine the interplay between these factors
both kinetically and at equilibrium. TF rapidly scans the ribosomes until it is stabilized on
ribosomes presenting TF-specific nascent chains. SRP binding to those complexes is strongly
impaired. Thus, TF in effect prevents SRP binding to the majority of ribosomes, except those
presenting SRP-specific signal sequences, explaining how the small amount of SRP in the cell
can be effective in membrane targeting. PDF and MAP do not interfere with TF or SRP binding
to translating ribosomes, indicating that nascent-chain processing can take place before or in
parallel with TF or SRP binding.
DOI: 10.1038/ncomms5180
1 Department of Physical Biochemistry, Max Planck Institute for Biophysical Chemistry, 37077 Go¨ttingen, Germany. Correspondence and requests for
materials should be addressed to W.W. (email: wolfgang.wintermeyer@mpibpc.mpg.de).
NATURE COMMUNICATIONS | 5:4180 | DOI: 10.1038/ncomms5180 | www.nature.com/naturecommunications 1
& 2014 Macmillan Publishers Limited. All rights reserved.
During protein biosynthesis, the nascent peptide chains ontranslating ribosomes are scanned by a number of proteinligands, called ribosome-associated protein biogenesis
factors (RPBs), such as the chaperone trigger factor (TF), the
signal recognition particle (SRP) and the processing enzymes
peptide deformylase (PDF) and methionine aminopeptidase
(MAP). RPBs bind to the ribosome close to the exit of the
emerging nascent peptide by attaching to a confined binding
platform comprising six ribosomal proteins surrounding the
polypeptide tunnel exit (Fig. 1). Whether co-translational binding
of these ligands is regulated and to which extent RPBs can bind
simultaneously or compete for binding is not clear1.
TF is an early-acting ribosome-associated chaperone that binds
nascent proteins emerging from the ribosome and prevents co-
translational misfolding of these proteins2–4. TF is present in the
cell in excess over ribosomes and potentially interacts with many
nascent proteins4,5, with a preference for hydrophobic stretches
flanked by positively charged amino acids6. Structural and
mechanistic aspects of TF function have been reviewed
recently4,7,8. SRP initiates the targeting of ribosome nascent-
chain complexes (RNCs) that are synthesizing membrane
proteins to the protein-conducting channel (translocon) in the
plasma membrane9–11. SRP scans translating ribosomes for
emerging hydrophobic signal-anchor sequences (SAS). Binding
to an SAS switches SRP to the targeting mode and initiates co-
translational membrane targeting by binding to the SRP receptor
and transfer to the translocon12,13. SRP and TF together can bind
to the ribosome, although both contact protein L23 at the peptide
exit (Fig. 1)3,14–18; changes in crosslinking patterns indicate that
conformational changes accompany the accommodation of the
two ligands on one ribosome19,20.
Depending on the functional state of the ribosome, the
interaction of SRP with ribosomes takes place in different time
domains. In the ‘scanning’ mode, SRP binds to non-translating
ribosomes or ribosomes that do not synthesize membrane
proteins in a readily reversible fashion13, with effective
dissociation rates in the range of 10 s! 1, allowing other RPBs
to bind in a stochastic fashion. However, the extent to which
RPBs can enter when SRP is stabilized on translating ribosomes
with short nascent chains (‘stand-by’; effective off-rate about
1 s! 1) or on ribosomes synthesizing membrane proteins
(‘targeting’; effective off-rate about 0.1 s! 1)12,13 is not clear.
The interplay of TF with other RPBs on the ribosome is not clear
as well, as it has been reported that TF binds to and dissociates
from ribosomes very slowly21–23, such that stably bound TF
might interfere with the binding of other RPBs.
Protein synthesis in bacteria starts with the incorporation of
formylated methionine. Deformylation by PDF and removal of
the N-terminal methionine by MAP are essential for the stability
and function of many proteins1. The C-terminal helix of PDF has
been located on the ribosome at protein L22 close to the peptide
exit, suggesting how PDF might bind24. Current models argue
that this location of PDF allows for early scanning and
deformylation of nascent chains when they just appear outside
the ribosomal exit tunnel. Deformylation and methionine
removal occur on 60–80% of all proteins and control the
stability of proteins, as the N-terminal amino acid determines the
susceptibility of many mature proteins for the cellular protein
degradation machinery25,26. It has been proposed that PDF and
TF act in a concerted fashion3, whereas recent data from selective
ribosome profiling indicated that TF and PDF do compete for
ribosome binding in vivo27. Conversely, on the basis of binding
data obtained in vitro, it was suggested that TF and SRP did not
compete with PDF for binding to ribosomes or RNCs28. Although
MAP binds to the ribosome at the peptide exit close to proteins
L17 and L23, it does not compete with TF or SRP, but strongly
competes with PDF28.
To obtain quantitative data on the interplay of RPBs, including
TF, SRP, PDF and MAP, at the peptide exit of the ribosome, we
monitor fluorescence resonance energy transfer (FRET) between
fluorophore-labelled ribosomes or RNCs and labelled TF or SRP.
To relate competition binding data to the stability of the complexes,
we measure the interaction of TF with non-translating ribosomes
as well as with RNCs, including the kinetics of complex formation
and dissociation. We observe that TF rapidly binds to, and
dissociates from vacant or translating ribosomes, unless nascent
chains comprising TF-specific binding sites are presented, which
strongly stabilize the complex. The competition between TF and
SRP and other RPBs for binding to the ribosome is examined at
equilibrium providing quantitative data that reveal the choreo-
graphy of RPBs at the ribosomal peptide exit. The data reveal that
simultaneous binding of TF and SRP to one ribosome lowers the
binding affinity about 10-fold. Thus, in effect, TF precludes SRP
binding to TF-specific RNCs. In contrast, the binding of PDF or
MAP to RNCs does not influence the binding of TF or SRP.
Results
Kinetics of TF interaction with non-translating ribosomes. To
determine the kinetics of TF–ribosome complexes, we monitored
TF binding to, and dissociation from, ribosomes by FRET between
ribosomes labelled with 7-Diethylamino-3-((((2-Maleimidyl)
ethyl)amino)carbonyl)coumarin (MDCC; donor) at position 21
of protein L23 (ref. 13) and TF labelled with Bodipy-FL (Bpy;
acceptor) at position 99. To examine the kinetics of ribosome–TF
complex formation, we rapidly mixed MDCC-labelled ribosomes
with TF(Bpy) and monitored the increase of the acceptor signal
(Fig. 2a). The signal change was single exponential, and long-time
measurements did not reveal any additional slow step
(Supplementary Fig. 1a). To verify that the signal change
observed on binding of labelled TF to ribosomes was due to
FRET, we performed a control experiment with ribosomes con-
taining cysteine-free wild-type L23, which had been reacted with
MDCC, leading to low-level incorporation of MDCC at proteins
other than L23. Essentially, no signal change was observed with
those ribosomes (Supplementary Fig. 1b), confirming that the
signal changes observed with L23-labelled ribosomes were due to
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Figure 1 | Binding platform for RPBs at the peptide exit of the bacterial
50S ribosomal subunit. Ribosomal proteins at or near the peptide exit of
the 50S subunit (grey outline) are indicated along with the RPBs binding to
protein L23 (SRP, TF), L22 (PDF) or L17 (MAP) (for references, see text).
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RNCs, as indicated by the loss of FRET with increasing
concentrations of PDF.
Small effect of MAP on ribosome binding of TF and SRP. It is
not known to which extent the binding of MAP, which may enter
RNCs early during protein synthesis, influences the binding of TF
or SRP. On addition of MAP in saturating concentrations, Kd
values for TF or SRP increased less than twofold for the com-
plexes with non-translating ribosomes or the respective RNCs
(Supplementary Fig. 5). Fluorescence amplitude changes were
small as well. These results indicate that MAP bound to ribo-
somes, as reported recently28, and did not displace TF or SRP
from non-translating ribosomes or RNCs or change affinities.
Discussion
One major finding of this paper is that TF rapidly forms transient
complexes with ribosomes. The kinetic stability of the complexes
depends on the functional state of the ribosomes and the nature
of the nascent peptide presented on the ribosome. Ribosome–TF
complexes form with second-order rate constants of
100–200mM! 1 s! 1, that is, complex formation is close to
diffusion controlled. The complexes are short-lived, with half-
life times of 60ms, when the ribosomes are vacant or present a
nascent protein lacking a TF-binding motif, such as in Lep75-
RNC; in these cases binding affinities are in the range of 0.1–
0.2 mM. The ribosome–TF complexes are strongly stabilized (20–
30-fold) and binding affinities are high (Kd values of 2–10 nM)
when RNCs expose nascent peptides encompassing TF-binding
sequences, such as in the proOmpA75- or HemK75-RNCs used
here. Up to about 20-fold higher Kd values of TF binding to
vacant ribosomes or various RNCs, including RNCs presenting
the nascent beta subunit of RNA polymerase, a TF substrate,
were reported previously31. However, those values were obtained
by pelleting ribosome–TF complexes, which apparently
underestimated affinities, in particular when the complexes
were unstable kinetically, such as the complexes with vacant
ribosomes or Lep-RNCs. The present parameters of TF–ribosome
interaction also differ from published values determined using
fluorescence-labelled TF21–23. In that work, half-life times around
10 s and equilibrium dissociation constants of 1–2 mM were
observed for the complexes of labelled TF with non-translating
ribosomes and half-life times up to 50 s for translating ribosomes
exposing TF-binding nascent chains21–23. However, as we show
here, the slow kinetics of complex formation and dissociation as
well as low-affinity binding observed in those experiments were
caused by the particular fluorescence label, BADAN at position
14, in TF that strongly influenced the properties of TF.
A transient character of ribosome–TF complexes resolves the
potential problem of slowly forming and long-lived TF complexes
with translating ribosomes, including non-substrate RNCs, which
might interfere with nascent-chain processing by PDF and MAP
and/or membrane targeting by SRP, despite concurrent binding.
Thus, rather than staying bound on translating ribosomes and
‘waiting’ for nascent peptides to emerge from the exit tunnel, as
suggested by the previously reported slow kinetics, the interaction
of TF with ribosomes appears highly dynamic. An off-rate of
about 12 s! 1 matches a translation rate of 10 s! 1 and, combined
with a high effective on-rate (E1,000 s! 1, based on an
approximate second-order association rate constant of
E100mM! 1 s! 1 and assuming E10 mM free TF monomer in
the monomer–dimer equilibrium32) allows TF to inspect many
translating ribosomes at appropriate speed and settle on
TF-specific sequences as soon as they emerge from the exit
tunnel. This may be important for the chaperone function of TF
in preventing premature, potentially erroneous folding of nascent
proteins.
Previous kinetic analyses revealed that, similar to what we
report here for TF, SRP scans ribosomes rapidly until binding is
stabilized on translating ribosomes that have their peptide exit
tunnel filled (‘stand-by’) or expose a signal-anchor sequence
(‘targeting’)13. Assuming an SRP concentration in vivo of 0.1 mM
and diffusion-controlled binding, as observed in vitro13, the
effective rate of SRP binding to ribosomes or RNCs is about
10 s! 1. This rate matches the rate of TF dissociation from non-
TF-substrate RNCs, Lep75-RNC in our experiments, which may
optimize the access of SRP to its substrate RNCs. The observed
destabilization of SRP binding to non-substrate RNCs by high-
affinity TF binding to TF-substrate RNCs enhances the
specificity, in particular of SRP, for binding to its substrate
RNCs (Fig. 6). Although SRP and TF can bind to ribosomes
concurrently, the destabilization has the consequence that SRP is
practically excluded from the large number of RNCs to which TF
is bound strongly5. Rather, SRP will predominantly be bound to
RNCs with short nascent peptides filling the exit tunnel and, in
particular, RNCs presenting an SAS, as SRP binds to those RNCs
with an apparent KdE20 nM even at saturation with TF, which is
well below the intracellular concentration of SRP of around
100 nM. Thus, the partial competitive binding behaviour of TF
and SRP in effect increases the specificity of the small amount of
SRP-specific
RNCs
Membrane
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0.5 s–1
TF-specific
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Figure 6 | Interplay of TF and SRP on translating ribosomes. Concurrent
binding of TF or SRP to RNCs presenting the respective specific nascent
chain (SRP-specific SAS, red; TF-specific sequence, blue) leads to
weakening of the binding of the respective other ligand (values of Kd
increased eightfold or 415-fold, respectively (Fig. 3)), as indicated by red
lines. Because SRP dissociates from RNCs in three steps, average values of
koff calculated from the three rate constants k! 1, k! 2 and k! 3 are given13.
Values of koff for TF dissociation from RNCs are taken from Table 1. Second-
order rate constants for TF or SRP binding to RNCs ranged from about 100
to 200mM! 1 s! 1 (Table 1 and ref. 13), indicating near diffusion-controlled
binding.
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Translation initiation is the process of assembly of 
elongation-competent 80S ribosomes, in which the ini-
tiation codon is base-paired with the anticodon loop 
of initiator tRNA (Met-tRNAMeti) in the ribosomal P-site1. 
It requires at least nine eukaryotic initiation factors 
(eIFs; TABLE 1) and comprises two steps: the formation 
of 48S initiation complexes with established codon–
anticodon base-pairing in the P-site of the 40S ribo-
somal subunits, and the joining of 48S complexes with 
60S subunits. On most mRNAs, 48S complexes form by 
a ‘scanning’ mechanism, whereby a 43S preinitiation 
complex (comprising a 40S subunit, the eIF2–GTP– 
Met-tRNAMeti ternary complex (eIF2 TC), eIF3, eIF1, 
eIF1A and probably eIF5) attaches to the capped 5` prox-
imal region of mRNAs in a step that involves the unwind-
ing of the mRNA’s 5` terminal secondary structure 
by eIF4A, eIF4B and eIF4F. The 43S complex then 
scans the 5` untranslated region (5` UTR) in the 5` to 3` 
direction to the initiation codon (FIG.1). After initiation 
codon recognition and 48S complex formation, eIF5 
and eIF5B promote the hydrolysis of eIF2-bound 
GTP, the displacement of eIFs and the joining of a 
60S subunit. Although most mRNAs use the scanning 
mechanism, initiation on a few mRNAs is mediated by 
internal ribosome entry sites (IRESs; BOX 1).
Here, we summarize the current state of knowledge 
concerning the mechanism of translation initiation in 
vertebrates and discuss the principles underlying its 
regu lation. We focus on examples in which the regula-
tory mechanism is well understood and/or the biological 
significance is particularly high, and we include evi-
dence from lower eukaryotes only when it enhances our 
understanding of the mechanisms in vertebrates.
Mechanism of 5` end-dependent initiation
The canonical mechanism of translation initiation can be 
divided into several stages (FIG.1), as described below.
Formation of 43S preinitiation complexes. Translation 
initiation requires a pool of separated ribosomal sub-
units. Translation is a cyclical process, and ribosomal 
subunits that participate in initiation derive from the 
recycling of post-termination ribosomal complexes 
(post-TCs), which comprise an 80S ribosome still 
bound to mRNA, P-site deacylated tRNA and at least 
one release factor, eukaryotic release factor 1 (eRF1). 
Post-TCs are recycled by releasing these ligands and 
dissociating ribosomes into subunits. At a low free 
(nucleotide-unbound) Mg2+ concentration (1 mM), 
recycling can be mediated by eIFs2. eIF3, in cooperation 
with its loosely associated eIF3j subunit, eIF1 and eIF1A, 
dissociates post-TCs into free 60S subunits and mRNA- 
and tRNA-bound 40S subunits. Subsequently, eIF1 pro-
motes release of the tRNA, after which eIF3j, which binds 
40S subunits with negative cooperativity with mRNA3,4, 
mediates mRNA dissociation. eIF3, and probably eIF1 
and eIF1A, remain associated with recycled 40S subu-
nits, preventing their re-association with 60S subunits. 
Recycling at even slightly elevated Mg2+ concentrations 
(which stabilize ribosomal subunit association) also 
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Met-tRNAMeti
The unique initiator tRNA, 
aminoacylated with 
methionine, that is used to 
initiate protein synthesis.  
Its anticodon is complementary 
to the AUG initiation codon;  
it forms a specific ternary 
complex with eIF2 and 
GTP and it binds to the 
ribosomal P-site.
P-site
The site on a ribosome that 
holds the tRNA that is linked 
to the growing peptide chain 
(peptidyl-tRNA).
The mechanism of eukaryotic 
translation initiation and principles 
of its regulation
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Abstract | Protein synthesis is principally regulated at the initiation stage (rather than during 
elongation or termination), allowing rapid, reversible and spatial control of gene expression. 
Progress over recent years in determining the structures and activities of initiation factors, 
and in mapping their interactions in ribosomal initiation complexes, have advanced our 
understanding of the complex translation initiation process. These developments have 
provided a solid foundation for studying the regulation of translation initiation by 
mechanisms that include the modulation of initiation factor activity (which affects almost all 
scanning-dependent initiation) and through sequence-specific RNA-binding proteins and 
microRNAs (which affect individual mRNAs).
 P O S T- T R A N S C R I P T I O N A L  C O N T R O L
REVIEWS
NATURE REVIEWS | MOLECULAR CELL BIOLOGY  VOLUME 10 | FEBRUARY 2010 | 113
© 20  Macmillan Publishers Limited. All rights reserved10
Internal ribosome entry site
A structure that is located in 
the 5` UTR or ORF of some 
mRNAs of cellular or viral 
origin. It mediates translation 
initiation independently of the 
5` end of mRNA by recruiting 
the ribosome directly to an 
internal position on the mRNA.
requires ATP-binding cassette subfamily E member 1 
(ABCE1) (A.V. Pisarev, M.A. Skabkin, V.P. Pisareva, O.V. 
Skabkina, A. Rakotondrafara, M.W. Hentze, C.U.T H. 
and T.V.P., unpublished observations), an essential mem-
ber of the ATP-binding cassette (ABC) family of proteins5. 
ABCE1 splits post-TCs into free 60S subunits and tRNA- 
and mRNA-bound 40S subunits, and subsequent release 
of P-site tRNA and mRNA from these 40S sub units also 
requires eIF3, eIF1 and eIF1A. Thus, eIF3, eIF1 and 
eIF1A are recruited to 40S subunits during recycling, 
whereas eIF2–GTP–Met-tRNAMeti subsequently attaches 
to recycled 40S subunits, bound simultaneously to eIF3, 
eIF1 and eIF1A, to form 43S complexes. Another protein 
that can prevent ribosomal subunit re-association, in this 
case by binding to 60S subunits, is eIF6, but its status 
as an initiation factor is uncertain (see Supplementary 
information S1 (box)).
Recent studies have yielded insights into the archi-
tecture of 43S complexes. Eukaryotic and prokaryotic 
small ribosomal subunits share a common structural 
core that includes the decoding centre, whereas addi-
tional eukaryotic ribosomal proteins (rps) and 18S rRNA 
expansion segments (rapidly evolving regions inter-
spersed throughout the conserved rRNA core that might 
Table 1 | Eukaryotic initiation factors
Name Number of subunits and 
their molecular mass (kDa)
Function
Core initiation factors
eIF2 3 (36.1, 38.4 and 51.1) Forms an eIF2–GTP–Met-tRNA
i
 ternary complex that binds to the 40S subunit, 
thus mediating ribosomal recruitment of Met-tRNA
i
eIF3 13 (800 total) Binds 40S subunits, eIF1, eIF4G and eIF5; stimulates binding of 
eIF2–GTP–Met-tRNA
i
 to 40S subunits; promotes attachment of 43S complexes 
to mRNA and subsequent scanning; and possesses ribosome dissociation and 
anti-association activities, preventing joining of 40S and 60S subunits
eIF1 1 (12.7) Ensures the fidelity of initiation codon selection; promotes ribosomal scanning; 
stimulates binding of eIF2–GTP–Met-tRNA
i
 to 40S subunits; and prevents 
premature eIF5-induced hydrolysis of eIF2-bound GTP and P
i
 release
eIF1A 1 (16.5) Stimulates binding of eIF2–GTP–Met-tRNA
i
 to 40S subunits and cooperates 
with eIF1 in promoting ribosomal scanning and initiation codon selection
eIF4E 1 (24.5) Binds to the m7GpppG 5` terminal ‘cap’ structure of mRNA
eIF4A* 1 (46.1) DEAD-box ATPase and ATP-dependent RNA helicase
eIF4G‡ 1 (175.5) Binds eIF4E, eIF4A, eIF3, PABP, SLIP1 and mRNA (see FIG. 3a) and enhances the 
helicase activity of elF4A 
eIF4F 3 (246.1 total) A cap-binding complex, comprising eIF4E, eIF4A and eIF4G; unwinds the 5` 
proximal region of mRNA and mediates the attachment of 43S complexes to it; 
and assists ribosomal complexes during scanning
eIF4B 1 (69.3) An RNA-binding protein that enhances the helicase activity of eIF4A
eIF4H 1 (27.4) An RNA-binding protein that enhances the helicase activity of eIF4A and is 
homologous to a fragment of eIF4B
eIF5 1 (49.2) A GTPase-activating protein, specific for GTP-bound eIF2, that induces 
hydrolysis of eIF2-bound GTP on recognition of the initiation codon
eIF5B 1 (138.9) A ribosome-dependent GTPase that mediates ribosomal subunit joining 
eIF2B 5 (33.7, 39.0, 50.2, 59.7 and 80.3) A guanosine nucleotide exchange factor that promotes GDP–GTP exchange 
on eIF2
Auxiliary factors
DHX29 1 (155.3) A DExH box-containing protein that binds 40S subunit and promotes 
ribosomal scanning on mRNAs with long, highly structured 5` UTRs
Ded1 1 (65.6) A DEAD box-containing NTPase and RNA helicase that potentially promotes 
scanning in Saccharomyces cerevisiae
eIF6 1 (26.6) An anti-association factor that binds 60S subunits and prevents them from 
joining to 40S subunits 
p97 1 (102.4) Closely related to the carboxy-terminal two-thirds of eIF4G; binds eIF4A and 
eIF3; and promotes initiation in a potentially mRNA-specific manner
PABP 1 (70.7) Binds to the 3` poly(A) tail of mRNA, eIF4G and eRF3; enhances binding of eIF4F 
to the cap; and might facilitate recruitment of recycled post-termination 40S 
subunits back to the 5` end of mRNA
Ded1, DEAD box helicase 1; DHX29, DExH box protein 29; eIF, eukaryotic initiation factor; PABP, poly(A)-binding protein. *Two paralogues (eIF4AI and eIF4AII), 
encoded by different genes, are functionally indistinguishable, but eIF4AIII has no activity as an eIF. ‡Two paralogues (eIF4GI and eIF4GII), encoded by different genes, 
are functionally similar but show some selectivity towards different mRNAs. eIF4GI is generally the more abundant.
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and the requirement for ATP and eIF4A is proportional 
to the degree of secondary structure26,27. Thus, in addition to 
promoting attachment, eIF4A, eIF4G and eIF4B assist 
43S complexes during scanning.
However, the mechanism by which these factors assist 
scanning remains unknown. Cryoelectron microscopy-
based modelling placed eIF4G at the 40S subunit’s trailing 
edge, near the E-site8 (FIG.2a), which would be consist-
ent with eIF4A, eIF4G and eIF4B acting by helicase- 
mediated ‘ratcheting’ of mRNA through the mRNA-
binding channel, whereas mRNA secondary structure 
would be unwound by the 40S subunits themselves at 
their leading edge. However, an alternative model, in 
which eIF4A, eIF4G and eIF4B unwind mRNA before it 
enters this channel, has also been suggested22 (FIG.3b).
Although ribosomal attachment is achieved by the 
cap–eIF4E–eIF4G–eIF3–40S chain of interactions, the fate 
of each link during the transition from attachment to 
scanning and during scanning per se is unclear. Their 
maintenance would cause 5` UTRs to ‘loop out’, allowing 
only one 43S complex to scan at a time, whereas break-
ing of even one link in the chain would permit multiple 
complexes to scan simultaneously on a single 5` UTR.
Another important question concerns the directional-
ity of scanning. The fact that initiation frequency at the 
5` proximal AUG is reduced by the presence of a nearby 
downstream AUG28 suggests that scanning may consist 
of forward (5` to 3`) thrusts alternating with limited relax-
ation over distances of a few nucleotides in the reverse 
direction.
Importantly, recent data obtained using yeast and 
mammalian systems suggest that initiation involves other 
DEAD box family members in addition to eIF4A, and 
that eIF4A can act with p97, a distinct eIF4G-related pro-
tein. Mammalian DExH box protein 29 (DHX29) binds 
40S subunits directly and is required for efficient scan-
ning through highly structured 5` UTRs in vitro29. In vivo, 
silencing DHX29 impairs translation, resulting in poly-
some disassembly and the accumulation of mRNA-free 
80S monomers30. DHX29 has been suggested to increase 
scanning processivity by influencing the conformation of 
the mRNA-binding channel at its entrance29.
Yeast DEAD box helicase 1 (Ded1) has also been 
implicated in initiation. Ded1 is likely to be a more potent 
helicase than eIF4A and their functions are not redun-
dant, suggesting that eIF4A promotes ribosomal attach-
ment whereas Ded1 assists scanning, particularly on long 
5` UTRs31–33. The involvement in initiation of DEAD 
box protein 3 (DDX3), a mammalian Ded1 homologue, 
is more controversial, although some data suggest that 
DDX3 depletion specifically affects translation of mRNAs 
with long, highly structured 5` UTRs34.
p97, which is ubiquitously expressed in the tissues 
of mammals, birds and some insects, is homologous to 
the C-terminal two-thirds of eIF4G and binds eIF4A 
and eIF3, but lacks an eIF4E-binding region35 (FIG.3a). 
p97 activates translation of uncapped mRNAs in vitro36 
and its role in translation of capped mRNAs is not fully 
redundant with that of eIF4G. Although depletion of 
eIF4GI and p97 individually impaired global transla-
tion by ~ 20–30% and co-depletion reduced it by ~ 60%, 
depletion of eIF4GI, but not of p97, selectively impaired 
translation of mRNAs containing upstream open reading 
frames (uORFs), suggesting that these factors promote 
initiation on different classes of mRNAs37.
Initiation codon recognition. To ensure the fidelity of 
initiation, scanning complexes must have a discrimi-
natory mechanism that prevents partial base pairing 
of triplets in the 5` UTR with the Met-tRNAiMet anti-
codon and promotes recognition of the correct initia-
tion codon. This is usually the first AUG triplet in an 
optimum context — GCC(A/G)CCAUGG, with a purine 
at the –3 and a G at the +4 positions (relative to the A of 
the AUG codon, which is designated +1)24. eIF1 plays the 
key part in maintaining the fidelity of initiation. It 
enables 43S complexes to discriminate against non-AUG 
triplets and AUG triplets that have poor context or are 
located within 8 nucleotides of the mRNA 5` end, and 
also disso ciates the ribosomal complexes that aberrantly 
assemble at such triplets in its absence15,38,39. Genetic 
studies in yeast also identified eIF1 as a determinant of 
initiation codon recognition40. In a current model, eIF1 in 
cooperation with eIF1A promotes a scanning-competent 
‘open’ conformation of the 43S complex14 (FIG.2c), but to 
establish stable codon–anticodon base-pairing, ribo-
somal complexes must undergo conformational changes 
that are antagonized by eIF1. Establishment of codon–
anti codon base pairing is accompanied by tightening 
of the eIF1A–40S interaction41 and eIF1’s displacement 
from near the P-site3,10,42, which switches the complex to 
a ‘closed’ conformation that is locked onto the mRNA. 
Consistently, yeast eIF1 mutants that dissociate more 
rapidly from 48S subunits enhance initiation at non-
AUG codons43. The eIF1A’s N-terminal and C-terminal 
tails, which reach into the P-site13 (FIG.2b), have oppo-
site effects on start codon selection: the C-terminal tail 
increases its stringency and was proposed to promote 
Figure 1 | Model of the canonical pathway of eukaryotic translation initiation. 
The canonical pathway of eukaryotic translation initiation is divided into eight stages 
(2–9). These stages follow the recycling of post-termination complexes (post-TCs; 1)  
to yield separated 40S and 60S ribosomal subunits, and result in the formation of an  
80S ribosomal initiation complex, in which Met-tRNAMet
i
 is base paired with the initiation 
codon in the ribosomal P-site and which is competent to start the translation elongation 
stage. These stages are: eukaryotic initiation factor 2 (eIF2)–GTP–Met-tRNAMet
i
  
ternary complex formation (2); formation of a 43S preinitiation complex comprising 
 a 40S subunit, eIF1, eIF1A, eIF3, eIF2–GTP–Met-tRNAMet
i
 and probably eIF5 (3);  
mRNA activation, during which the mRNA cap-proximal region is unwound in an 
ATP-dependent manner by eIF4F with eIF4B (4); attachment of the 43S complex to this 
mRNA region (5); scanning of the 5` UTR in a 5` to 3` direction by 43S complexes (6); 
recognition of the initiation codon and 48S initiation complex formation, which switches 
the scanning complex to a ‘closed’ conformation and leads to displacement of eIF1 to 
allow eIF5-mediated hydrolysis of eIF2-bound GTP and P
i
 release (7); joining of 60S 
subunits to 48S complexes and concomitant displacement of eIF2–GDP and other 
factors (eIF1, eIF3, eIF4B, eIF4F and eIF5) mediated by eIF5B (8); and GTP hydrolysis  
by eIF5B and release of eIF1A and GDP-bound eIF5B from assembled elongation- 
competent 80S ribosomes (9). Translation is a cyclical process, in which termination 
follows elongation and leads to recycling (1), which generates separated ribosomal 
subunits. The model omits potential ‘closed loop’ interactions involving poly(A)-binding 
protein (PABP), eukaryotic release factor 3 (eRF3) and eIF4F during recycling (see 
Supplementary information S5 (box)), and the recycling of eIF2–GDP by eIF2B. Whether 
eRF3 is still present on ribosomes at the recycling stage is unknown.
◀
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GTPase-activating protein
A protein that stimulates the 
intrinsic ability of a GTPase to 
hydrolyse GTP to GDP.
Arginine finger
A catalytic residue that was 
first defined for RasGAPs,  
and that supplies a catalytic 
arginine residue into the active 
site of Ras to increase the 
reaction rate.
Commitment of ribosomes to a start codon. Initiation 
codon recognition is followed by a step during which 
the arrested ribosome becomes committed to initia-
tion at that codon. The commitment step is mediated 
by eIF5, an eIF2-specific GTPase-activating protein 
(GAP)1. eIF5 binds to eIF2’s β-subunit but induces the 
GTPase activity of eIF2’s γ-subunit only in eIF2–GTP–
Met-tRNAMeti complexes that are bound to 40S sub units. 
eIF5 has been proposed to act as a classical GAP by 
providing an arginine finger45. An alter native hypothesis 
suggests that eIF5 derepresses eIF2γ’s GTPase activity46. 
Premature hydrolysis of eIF2-bound GTP in 43S com-
plexes, and particularly subsequent Pi release, are pre-
vented by eIF13,47. Establishment of codon–anticodon 
base pairing results in eIF1’s displacement42, which 
relieves repression of GTP hydrolysis and Pi release3,47. 
Thus, in addition to its role in initiation codon selec-
tion during 48S complex formation, eIF1 also maintains 
initiation fidelity at a later stage by linking hydrolysis 
of eIF2-bound GTP with the establishment of codon–
anticodon base pairing. Importantly, in addition to 
eIF1, genetic suppressor studies in yeast also implicate 
eIF2 and eIF5 in ensuring the fidelity of initiation codon 
selection40. GTP hydrolysis reduces eIF2’s affinity for 
Met-tRNAMeti, leading to partial dissociation of eIF2–
GDP from 40S subunits39,48. eIF2B mediates guanine 
nucleotide exchange on eIF2, recycling it for the next 
initiation round1.
Ribosomal subunit joining. Joining of 60S subunits and 
dissociation of eIF1, eIF1A, eIF3 and residual eIF2–
GDP are mediated by eIF5B3,49, a ribosome-dependent 
GTPase that is homologous to prokaryotic initiation fac-
tor IF2 (REF. 1) Hydrolysis of eIF5B-bound GTP is not 
required for subunit-joining, but is essential for eIF5B’s 
own release from assembled 80S ribosomes1. eIF5B and 
IF2 occupy the same region in the intersubunit cleft50, 
which was proposed to promote subunit joining by bury-
ing large solvent-accessible surfaces on both sub units12. 
eIF5B alone can partially displace eIF2–GDP from 
40S subunits, whereas complete dissociation occurs only 
in the presence of 60S subunits during the actual subunit 
joining event39. Interaction of the C-terminal domain 
of eIF5B with the C-terminal tail of eIF1A51,52, which 
probably becomes possible only after the displacement 
of eIF1A’s C-terminal tail from the P-site (FIG.2b) on ini-
tiation codon recognition13, is required for efficient sub-
unit joining and GTP hydrolysis by eIF5B. This indicates 
that eIF1A remains associated with ribosomal complexes 
throughout the subunit joining process and dissociates 
from assembled ribosomes with eIF5B53,54. Although 
those eIFs that bind to the interface of the 40S subunit 
must be released before or at subunit joining, dissociation 
of eIF3 and eIF4G, which are largely bound to the solvent 
side (FIG.2a), may be delayed (as discussed below).
Reinitiation after a short upstream ORF. About 45–50% 
of mammalian genes (but only ~ 13% of yeast genes) 
encode mRNAs that have at least one short uORF 
(typically < 30 codons) upstream of the main protein 
coding ORF55–57. In these cases, some (usually < 50%) 
of the ribosomes that have translated the uORF resume 
scanning and reinitiate at downstream sites. Post-
termination events at uORF stop codons probably 
proceed conventionally, with release of 60S subunits fol-
lowed by deacylated tRNA, but some 40S subunits then 
remain on the mRNA and resume scanning. At this 
stage, such 40S subunits are incompetent for reinitia-
tion because they lack an eIF2-TC, but this does not 
prevent scanning, during which a new eIF2-TC can 
be acquired. eIF2-TC availability determines how far 
40S subunits migrate before acquiring one.
Rescanning and reinitiation efficiency decreases 
quite abruptly with increasing length of the uORF58, or 
if the uORF includes stable RNA secondary structures 
Figure 2 | Architecture of ribosomal initiation compl x s. a | Model of a 40S subunit 
with eIF3 (magenta) on its exterior (solvent) surface and eIF4G (purple) bound to eIF3 
near the E-site, based on cryoelectron microscopy analysis, and showing positions of 
mRNA (red line) and eIF1 (green) on the subunit interface. Binding of eIF3 to the solvent 
surface of the 40S subunit is compatible with its potential partial retention on ribosomes 
during translation of short upstream open reading frames (uORFs). b | Positions of eIF1 
(magenta) and eIF1A (with its structured domain in light blue, its carboxy-terminal tail in 
dark blue and its amino-terminal tail in green) on the 40S subunit, relative to mRNA (red) 
and P-site tRNA (yellow), based on directed hydroxyl radical probing data10,13 and 
modelled using Thermus thermophilus 30S subunit crystal structures (protein data bank 
codes 1JGO and 1JGP). c | Cryoelectron microscopy reconstructions of yeast apo 40S 
subunits (left panel) and 40S–eIF1–eIF1A complexes (right panel), labelled to indicate the 
A-site, P-site and E-site in the mRNA-binding channel and the positions of rRNA helices 
h16, h18 and h34, which are involved in forming the mRNA entry channel (h18–h34) and 
the eIF1- and eIF1A-induced head–shoulder connection (h16–ribosomal protein S3 
(rpS3); indicated by an asterisk). Part a is adapted, with permission, from REF. 8 © 
American Association for the Advancement of Science (2005). Part c is adapted, with 
permission, from REF. 14 © Cell (2007).
REVIEWS
NATURE REVIEWS | MOLECULAR CELL BIOLOGY  VOLUME 10 | FEBRUARY 2010 | 119
© 20  Macmillan Publishers Limited. All rights reserved10
and downstream physiological responses (Scheme 2A). For in-
stance, Peleg et al. suggested that the memory impairment in
aged mice is due to the deregulation of histone H4 Lys12 ace-
tylation, which impairs a hippocampal gene expression pro-
gram associated with memory consolidation.[18] Interestingly,
this learning-induced gene expression can be reinstated by
treating mice with a KDAC inhibitor.[18] Lysine acetylation does
not function in isolation and is often tightly coupled with
other histone modifications (methylation, phosphorylation,
ubiquitylation, and others) to orchestrate the recruitment of di-
verse proteins such as chromatin-remodeling enzymes and
transcription factors to create actively transcribed euchromatin
or transcriptionally inactive heterochromatin (Scheme 2A).[3]
Lysine acetylation of histones has become a widely appreciat-
ed mechanism for epigenetic regulation of gene expression
that contributes to many cellular phenotypes.[1–3]
Lysine acetylation can occur on other cellular proteins be-
sides histones. One of the first examples of non-histone lysine-
acetylated protein was p53 tumor suppressor protein.[19] Like
histones, p53-mediated anti-proliferative events are regulated
by the coordination of lysine acetylation and various PTMs. For
instance, Gaudet et al. showed that p53 methylation on Lys369
is required for the recruitment of KAT Tip60 for acetylation of
p53, and reduced acetylation attenuates p53-induced apopto-
sis in response to DNA damage (Scheme 2B).[20,21] Thousands
of lysine-acetylated proteins have since been discovered in eu-
karyotes and prokaryotes by MS-based proteomics, including
protein chaperones, tubulin isoforms and metabolic en-
zymes,[4–6,22–24] which suggests broader and unexplored roles of
lysine acetylation.
N-Terminal Acetylation
N-terminal acetylation (Nt-acetylation) is an irreversible modifi-
cation that occurs during protein synthesis and maturation
(Scheme 1B). After the leader methionine in eukaryotes or for-
mylmethionine in prokaryotes is removed, Nt-acetylation is
executed by N-acetyltransferases, including NatA, NatB and
NatC.[25] MS-based proteomic analysis has revealed that 84% of
human proteins as well as about 57% of yeast proteins are
acetylated at their N termini.[7] Despite the large pool of Nt-
acetylated proteins, little is known about the precise roles of
Nt-acetylation. Varshavsky and co-workers have demonstrated
that Nt-acetylation can serve as a specific recognition motif for
the Doa10 ubiquitin ligase to target Nt-acetylated proteins for
proteasome-mediated degradation.[9] These studies suggested
that differential Nt-acetylation of proteins might serve as a
gatekeeping mechanism to regulate protein expression levels
in cells.
Serine and Threonine Acetylation
Serine and threonine acetylation was discovered in the context
of bacterial infection of eukaryotic cells (Scheme 1C).[10,26] The
bacterial effector YopJ secreted by pathogen Yersinia pestis
through the type III secretion system (T3SS) exhibits acetyl-
transferase activity when translocated into the host cells.[27]
YopJ appears to acetylate critical serine and threonine residues
located on the activation loop of mitogen-activated protein
kinase kinases (MAPKK) and IkB kinase (IKK) to block serine
and threonine phosphorylation required for downstream
MAPK and NF-kB signaling pathways involved in host inflam-
matory responses (Scheme 2C). A similar acetyltransferase ac-
tivity has also been suggested for another bacterial effector
protein, AvrA, which is secreted by Salmonella enterica via
T3SS to suppress host c-Jun N terminal kinase (Jnk) and NF-kB
signaling pathways.[11] These results show that bacterial patho-
gens can manipulate host cell biology through a unique form
of protein acetylation not previously described in eukaryotes
or bacteria alone. The studies highlight other classes of protein
acetylation that might not be fully realized and only occur in
specific biological contexts such as microbial infections.
Protein Acetylation Detection Methods
The detection of protein acetylation is crucial for characterizing
new substrates and their regulatory mechanisms. In this sec-
tion, we review the utility and limitations of commonly used
detection methods such as radiolabeling, anti-acetyllysine anti-
bodies and mass spectrometry for the analysis of protein ace-
tylation. Radiolabeling is often employed for visualizing acety-
Scheme 2. Schematic representation of the biological functions of protein
acetylation in gene transcription and bacterial infection. A) Lysine acetylation
on histones activates gene transcription by opening the access of promoter
region to RNA polymerases and transcription factors and by recruiting the
chromatin-remodeling complex containing bromodomain (BRMD), such as
SAGA complex. B) In response to genotoxic stress, lysine methylation on p53
recruits KATs such as Tip60 for lysine acetylation which leads to activation of
proapototic gene transcription, thereby cell apoptosis.[20,21] C) Yersinia effec-
tor protein YopJ, functioning as an acetyltransferase in host cells, blocks spe-
cific Ser/Thr phosphorylation sites of MAPKK with acetyl groups to inhibit
the downstream MAPK signaling pathway.[10]
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lated proteins and monitoring KAT enzyme activity
(Scheme 3A).[19,28, 29] For example, metabolic labeling of cells
with [3H]/[14C]-sodium acetate[19] enables radioactive labeling of
acetylated proteins, which can be separated by SDS-PAGE and
visualized by autoradiography. It is often difficult to determine
specific acetylation of proteins from these experiments, as
metabolic labeling of living cells with [3H]/[14C]-sodium acetate
might target diverse biomolecules given acetyl-CoA is a meta-
bolic precursor for many biosynthetic pathways. Alternatively,
specific KAT substrates can be characterized by labeling protein
substrates with [3H]/[14C]-acetyl-CoA in vitro.[28] For example,
Lin et al. utilized in vitro KAT assay on proteome micorarrays
with [14C]-acetyl-CoA to identify specific substrates of nucleo-
some acetyltransferase of H4 (NuA4) complex across the yeast
proteome.[29] This approach uncovered phosphoenolpyruvate
carboxykinase (Pck1p) as the substrate of NuA4 which acety-
lates Pck1p at lysine 514. Interestingly, Lin et al. revealed that
acetylation of K514 is essential for Pck1p gluconeogenic activi-
ty; this suggests yeast NuA4 complex functions as a regulator
in gluconeogenesis and cellular lifespan.[29] Although radioac-
tive labeling of proteins in cells and in vitro can be useful for
monitoring protein acetylation, optimal signals usually take
weeks to acquire due to the relatively low sensitivity of this
method, and the method is also hazardous to execute.
A number of anti-AcLys antibodies have been generated for
the detection of lysine acetylation (Scheme 3B). Compared to
radiolabeling, antibodies serve as efficient reagents for visuali-
zation of both in vitro and endogenously acetylated proteins
by immunoblotting.[30] Antibodies also enable analysis of spe-
cific protein acetylation sites. For example, Fraga et al. generat-
ed four different sequence-specific acetyllysine antibodies,
AcK16-H4, AcK12-H4, AcK8-H4, and AcK5-H4, to characterize
which lysine residue of histone H4 was differentially acetylated
in many cancer cell lines compared to healthy tissues.[31] These
findings and additional experiments with mass spec-
trometry indicated that aberrant regulation of his-
tone acetylation is associated with the cancerous cel-
lular states, which suggested that histone acetylation
patterns might serve as markers of cancer prognosis.
This study highlights the utility of antibodies for
monitoring specific lysine acetylation sites, nonethe-
less, the results from sequence-PTM-specific antibod-
ies need to be carefully interpreted and validated
with other methods because antibodies might be
cross-reactive with other epitopes or additional pro-
tein modifications might alter antibody binding.
Anti-pan-AcLys antibodies recognizing diverse pep-
tide sequences flanking the acetyllysine residues
have become instrumental in discovering new lysine-
acetylated proteins. These antibodies enable the
retrieval and enrichment of relative low-abundance
lysine-acetylated peptides from complex biological
mixtures for peptide sequencing by LC-MS/MS
(Scheme 3B).[4–6,22–24] These proteomic studies have
led to the discovery of thousands of lysine-acetylated
proteins and acetylation sites in both eukaryotic cells
and prokaryotic cells.[4–6,22–24] Lysine acetylation previ-
ously described were predominantly associated with transcrip-
tional regulation and chromosomal processes,[32–34] and the
acetylated proteins previously found mainly locate either in
nuclei or shuttle between nuclei and cytoplasm. MS-based
techniques significantly expanded the acetylome repertoire
and revealed that lysine acetylation ubiquitously exists in a va-
riety of cellular compartments as well as proteins possessing
diverse functionalities and involving in a range of cellular pro-
cesses, such as metabolism, protein folding, signaling, cell
cycle, and RNA splicing.[4–6,22–24] The large-scale lysine acety-
lome analysis of both E. coli[24] and Salmonella enterica[5] also
revealed lysine acetylation abundantly presents in bacteria and
suggested the regulatory mechanisms of lysine acetylation are
evolutionarily conserved from bacteria to mammals.
Mass spectrometry in combination of anti-AcLys antibodies
also allows quantitative analysis of protein acetylation by met-
abolic incorporation of stable isotope-labeled standards such
as 2H4-lysine,
13C6-arginine and
15N4-arginine onto proteins.
[4]
This quantitative proteomic technique is termed stable-isotope
labeling with amino acids in cell culture (SILAC)[35] and has
been employed by Choudhary et al.[4] to detect the global
changes of acetylome in response to two KDAC inhibitors, sub-
eroylanilide hydroxamic acid (SAHA)[36] and MS-275[37] by LC-
MS/MS. SAHA has been clinically used for the treatment of cu-
taneous T cell lymphoma; however, its anticancer mechanisms
and protein targets are still unclear. In the study of Choudhary
et al. , SILAC was used in combination with anti-pan-AcLys-anti-
body enrichment to determine the targeted acetylation sites
by KDAC inhibitors. This study demonstrated the utility of
quantitative proteomics in unraveling the downstream targets
and the specificities of KDAC inhibitors.
Anti-acetyllysine antibodies with broad specificity have also
enabled the discovery of two novel PTMs on lysine residues,
lysine propionylation and butyrylation, which are structurally
Scheme 3. Detection methods for the visualization and identification of acetylated pro-
teins. A) Radiolabeling of proteins with [3H]/[14C]-AcCoA enable the detection of KAT ac-
tivity in vitro. B) Anti-AcLys antibodies can be utilized to either visualize acetylated pro-
teins by immunoblotting or retrieve acetylated peptides from biological mixtures for LC-
MS/MS analysis.
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noyl-CoA functions as an acetyl-CoA analogue. Additionally, in
vitro p300 KAT assays showed that 4-pentynoyl-CoA exhibited
a comparable kcat/KM value as acetyl-CoA, suggesting 4-penty-
noyl-CoA can serve as a useful in vitro chemical tool to study
KAT p300 activity.
Bioorthogonal chemical reporters of protein acetylation can
also function in living cells. For example, sodium 4-pentynoate
can be utilized by endogenous KATs in living cells to visualize
acetylation of endogenous proteins such as histones
(Scheme 4C).[50] In addition, reaction of 4-pentynoate-modified
proteins with an azido-azobenzene-based cleavable biotin tag
(azido-azo-biotin)[50, 61] enabled the efficient recovery of 4-pen-
tynoate-modified proteins and peptides from cell lysates for
proteomic studies (Scheme 4C). The application of this bioor-
thogonal chemical proteomic strategy to Jurkat T cells revealed
194 4-pentynoate-labeled proteins,[50] 86% of which were also
identified by anti-acetyl-Lys proteomic studies.[4] Moreover, MS/
MS analysis confirmed 4-pentynoate moiety was installed onto
the known lysine acetylation sites of histones H2B, H3, and H4
in cells. These results demonstrated that sodium 4-pentynoate
can serve as an efficient chemical reporter for protein acetyla-
tion in living cells.
Chemical reporters in combination with bioorthogonal liga-
tion methods have afforded new tools to monitor protein ace-
tylation. Fluorescent detection of protein acetylation provides
a more sensitive method to visualize acetylation compared to
radiolabeling. These advances afford new opportunities for
high-throughput analysis of KAT substrates in vitro and identifi-
cation of novel acetylated proteins from cell lysates by using
bioorthogonal proteomic methods. For cellular studies, it is no-
table that chemical reporters target newly acetylated proteins,
which could be complementary to SILAC for evaluating the
Scheme 4. Detection of acetylated proteins by using acetylation chemical reporters. A) Mercaptoacetate-labeled proteins can be retrieved from the biological
mixtures by mercury-affinity column chromatography for LC-MS/MS analysis.[48] B) Chloroacetyl-CoA can be utilized by RimL and Hat1 to label proteins in
vitro. KAT activity can be monitored by reaction of chloroacetyl groups appended on proteins with a thiol-containing visualization tag, cysteamine-TAMRA.[49]
C) Sodium 4-pentynoate and 4-pentynoyl-CoA can be respectively utilized by KATs in living cells and in vitro.[50] The incorporated alkyne group serves as a
unique functionality in cell lysates, which can be further elaborated with an azide-functionalized fluorescent tag for visualization or a cleavable biotin tag for
acetylome profiling.
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changes of acetylome profiles in response to drugs or different
cellular states. Given the complexity of KAT activities that are
controlled by accessory factors and unique protein com-
plexes,[12,62] the union of bioorthogonal acetylation reporters
with “bump-hole” approaches[63] in the future might allow the
identification of specific KAT substrates. In contrast to anti-
AcLys antibodies which can be specific to acetylated peptide
sequences, chemical reporters provide general tools that can
be used to investigate serine or threonine acetylation associat-
ed with microbial infections or other unappreciated types of
protein acetylation. These bioorthogonal chemical reporters
provide readily accessible non-radioactive reagents that should
complement specific antibodies and mass spectrometry to ex-
plore protein acetylation in physiology and disease.
Preparation of Homogeneously Acetylated
Proteins for Functional Studies
The advent of detection methods for protein acetylation has
revealed thousands of acetylated proteins and acetylation sites
in both eukaryotes and prokaryotes.[4–6, 22–24] However, our un-
derstanding toward the biological consequences of individual
acetylation site as well as its underlying regulation mechanism
is still greatly hampered by the inherent heterogeneity exhibit-
ed in most of the acetylated proteins. Histones, for example,
are modified with methylation, acetylation, phosphorylation,
ubiquitylation, and other modifications. Moreover, the modifi-
cation status for each of the histones can be varied at different
microenviroments, thus complicating the efforts towards
discerning the roles played by protein acetylation. To address
these challenges, homogeneous proteins with defined acetyla-
tion sites should serve as unambiguous tools to unravel the
specific roles of acetylation.[64] Here we survey three ap-
proaches that have been used to prepare homogeneously ace-
tylated proteins and their biological applications (Scheme 5).
Specific chemical modification of recombinant proteins with
acetyllysine mimics often provides convenient means for gen-
erating acetylated proteins for structure–function studies. Cys-
teine residues with distinct nucleophilic reactivity represent at-
tractive targets for site-specific installation of desired modifica-
tions. For example, Simon et al. have previously generated the
analogues of lysine-methylated proteins by alkylating cysteine
residues with mono-, di-, or tri-methyl groups.[65] The chemical-
ly-modified histone H3 proteins containing methyl-thiaLys9
residues can be successfully reconstituted into histone octa-
mers, recognized by anti-methyllysine antibody and are func-
tionally similar to their natural counterparts. A similar approach
has been developed by Huang et al. by using methylthiocar-
bonyl-aziridine to site-specifically install acetyllysine analogue
into proteins by alkylation of cysteine residues (Scheme 5A).[66]
The chemically acetylated K4Ac/K8Ac-histone H4 tails and K9Ac-
histone H3 (C110A/K9C) maintained the capability to interact
with their binding proteins such as the bromodomain of Brdt
and anti-AcK antibodies. This strategy relies on cysteine elabo-
ration in order to attain selective cysteine alkylation. However,
mutation of native cysteine residues is sometimes not tolerat-
Scheme 5. Synthesis of homogeneously acetylated proteins for structure–function analysis. A) Chemoselective modification of cysteine residues to install
AcLys mimics onto the specific sites of proteins.[66] B) Semisynthesis of proteins with defined acetylation site by expressed protein ligation.[74] C) Site-specific
incorporation of AcLys into recombinant proteins by using N e-AcLys-tRNA synthetases/tRNACUA pair.
[76–78]
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